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Résumé 
Cette thèse décrit le développement et la méthodologie pour la synthèse de 2-pyrazolo[1,5-
a]pyridines à partir d’ylures de N-iminopyridinium et d’halogénures de styryle.  Des 
dérivés de chaque ylure de N-iminopyridinium et d’halogénures de styryle ont été utilisés 
pour la synthèse de plusieurs composés avec un intérêt pharmaceutique. 
Le premier chapitre présente les précédents littéraires pour la synthèse de 
pyrazolopyridines. Spécifiquement trois types différents de synthèse seront présentés en 
détail. L’importance biologique de ces composés sera discutée. La vue d’ensemble des 
travaux développés dans notre groupe de recherche pour la synthèse des produits de départ 
sera présentée brièvement. Finalement, la science intéressante qui a apporté cette idée de 
recherche sera révélée. 
Le deuxième chapitre décrit les résultats des optimisations étudiées pour la synthèse des 2-
phénylpyrazolo[1,5-a]pyridines à partir d’ylures de N-benzoyl-iminopyridinium et d’iodure 
de styryle. Chaque substrat de la réaction a été étudié individuellement afin d’être optimisé; 
les ratios, les solvants, la température du milieu réactionnel et le temps optimal de la 
réaction ont aussi été explorés.  
Le troisième chapitre présente l’étendue de la synthèse des pyrazolopyridines. L’étendue de 
la réaction inclut les dérivés des halogénures de styryle. L’étendue de la réaction a été 
élargie aux dérivés d’ylures de N-iminopyridinium et ils incluent des groupements 
donneurs d’électrons ainsi que des groupements pauvres en électrons. Des groupements 
exotiques d’iodure et de bromure de vinyle ont aussi été explorés. 
Le quatrième chapitre démontre les études mécanistiques que l’on a faites pour mieux 
comprendre les cycles catalytiques qui ont lieu durant la réaction. Des études de cyclisation 
avec les ylures de N-iminopyridinium ont été explorées pour les produits de départ 
suivants: iodure de styryle et phényl acetylène. 
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Abstract 
This thesis describes the development of a methodology for the one-pot synthesis of 2-
pyrazolo[1,5-a]pyridines from N-iminopyridinium ylide and styryl-halide starting 
materials. Both N-iminopyridinium ylide derivatives and styryl-halide derivatives were 
employed for the synthesis of various pharmaceutically interesting pyrazolo[1,5-
a]pyridines. 
The first chapter presents the literature precedents for the synthesis of pyrazolopyridines. 
More specifically, three different types of syntheses will be shown in detail. Furthermore, 
the biological importance of these compounds will be discussed. An overview of the 
developed methodologies previously carried out in our research group for the synthesis of 
the starting materials will be presented. Finally, the copper-catalyzed direct alkenylation of 
N-iminopyridinium ylides that brought about this research idea will be discussed. 
The second chapter describes the results of the optimization studies for the synthesis of 2-
phenyl pyrazolo[1,5-a]pyridines from N-benzoyliminopyridinium ylides and styryl iodides. 
Each component of the reaction was individually screened and the loading ratios were 
optimized: e.g., solvent and temperature.  
The third chapter presents the scope of the pyrazolopyridine synthesis. The scope includes 
styryl iodide, –bromide and –chloride derivatives. The scope of the reaction was extended 
to N-iminopyridinium ylide derivatives and included electron donating and electron 
withdrawing groups. Substituted vinyl iodides and bromides were also investigated. 
The fourth chapter demonstrates the mechanistic studies conducted in order to obtain an 
accurate understanding of the catalytic cycles taking place during the reaction. Cyclization 
studies were explored for both styryl iodides and phenyl acetylene starting materials reacted 
with N-iminopyridinium ylides. 
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Chapter 1: The chemistry of pyrazolo[1,5-a]pyridines 
1.1 Introduction 
Nitrogen containing heterocycles are important components of small molecule drug 
candidates.1 A recent survey of lead compounds under development in the pharmaceutical 
industry showed that 113 of 128 compounds, contained aromatic heterocycles and of those, 
107 contained nitrogen heterocycles; pyridines constituted the most important class of 
heterocycles.1 These findings show clearly the biological relevance of pyridine containing 
compounds. There has thus been much interest in developing novel and efficient methods 
for pyridine heterocycle synthesis.  
1.1.1 Pyrazolopyridines 
Pyrazolopyridines are nitrogen containing 10-π aromatic bicyclic heterocycles. The 
pyrazolopyridine class of compounds is biologically important, in part because they are 
indole isosteres.2 Indoles are biologically active, but their metabolic instability reduces 
their pharmaceutical utility.2 Pyrazolo[1,5-a]pyridines are found as part of the skeletal 
backbone of many therapeutic drugs today.1 Five pyrazolopyridine isomers exist as shown 
in Figure 1. The pyrazolopyridine isomers obtain their name and numbering system 
according to the Hantzsch-Widman nomenclature.3 
 
 
 
 
                                                
1 Carey, J. S.; Laffan, D.; Thompson, C.; Williams, M. T. Org.Biomol.Chem. 2006, 4, 2337. 
2 Aboul-Fadl, T.; Lober, S.; Gmeiner, P. Synthesis 2000, 12, 1727. 
3 (a) Eicher, T.; Hauptmann, S.; Speicher, A. Structure, Reactions, Syntheses, and Applications. In The 
Chemistry of Heterocycles, Suschitzky, H. ; Suschitzky, J. Wiley-VCH, Salford, 2003, 2nd ed.; p 5. (b) G. 
Jones, In Comprehensive Heterocyclic Chemistry II, Katritzky, A. R.; Rees, C. W.; Scriven, E. F. V. 
Pergamon, Oxford, 1996, Vol 8, 251. (c) Ramsden, C. A. In Comprehensive Heterocyclic Chemistry II, 
Katritzky, A. R.; Rees, C. W.; Scriven, E. F. V. Pergamon, Oxford, 1996, Vol 7, 283. 
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Figure 1: Pyrazolopyridine analogues 
N
[1,5-a]
N N NH
N
N
N
H
N
N N
H
N
N
N
H
N
[3,4-b] [4,3-b] [4,3-c][3,4-c]
1 2 3 4 5  
1.1.2 Biological activity 
Pyrazolo[1,5-a]pyridines exhibit a wide range of biological activity including psycho-
active effects on the nervous system: they have been put into a number of applications, 
such as an anti-psychotic agent, a D4 and D3 receptor antagonist and agonist, and an anti-
herpetic.4,5 
Pyrazolopyridines are found among many systems that affect the central nervous system. A 
pyrazolo[1,5-a]pyridine derivative 11 (Figure 2) has been found to be an active D4 
antagonist.6 The dopamine D3 receptor subtype is associated with several neuropathologies 
such as schizophrenia, attention-deficit disorder, unipolar major depression, and 
Parkinson’s disease.4 The D3 receptor controls dopamine synthesis, release, and neuronal 
firing.4 D3 receptor partial agonists can also inhibit cocaine-seeking behavior without 
providing rewarding effects.7 Some pyrazolo[1,5-a]pyridines derivatives are potent D3 
partial agonists (compound 7, Figure 2), used for treating psycho-stimulant addiction. The 
D3 antagonist 6 (Figure 2) is used as treatment of schizophrenia.4,7 
Compound 10 (Figure 2) has proven to be an active antiherpetic agent.5 Although acyclovir 
and its prodrug valacyclovir, which inhibit viral DNA synthesis, are safe and effective 
treatments for herpes simplex virus 1 and 2 (HSV-1 and HSV-2 respectively), other 
treatments have been pursued with different modes of action.5 For example, pyrazolo[1,5-
                                                
4 Lober, S.; Hubner, H.; Gmeiner, P. Bioorg. Med. Chem. Lett. 2002, 12, 2377. 
5 Johns, B. A.; Gudmundsson, K. S.; Turner, E. M.; Allen, S.H.; Samano, V. A.; Ray, J. A.; Freeman, G. A.; 
Boyd, F. L. Jr.; Sexton, C. J.; Selleseth, D. W.; Creech, K. L.; Moniri, K. R. Bioorg. Med. Chem. 2005, 13, 
2397. 
6 Lober, S.; Hubner, H.; Gmeiner, P.  Bioorg. Med. Lett. 1999, 9, 97. 
7 Bettinetti, L.; Schlotter, K.; Hubner, H.; Gmeiner, P. J. Med. Chem. 2002, 45, 4594. 
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a]pyridines derivatives have given similar or better antiviral activity on HSV-1 and HSV-
2.5 
Pyrazolo[1,5-a]pyridine derivative 9 (Figure 2) is a potent and selective 5HT3 antagonist.8 
Seratonin 5HT3 receptor antagonists have been used clinically for the treatment of emesis 
evoked by cancer chemotherapy.8 Furthermore, these compounds have proven to be active 
against anxiety, schizophrenia, memory disorders and drug dependency in animal models.8  
In addition, pyrazolo[1,5-a]pyridine derivatives 8 and 12 (Figure 2) are adenosine A1 
receptor antagonists with potent diuretic activity.9,10 Much effort in the last several decades 
has been devoted to developing adenosine antagonists and agonists; however, only 
adenosine itself has been approved for the treatment of cardiac arrhythmias and for the 
diagnosis of ischemic heart diseases.9 
Figure 2: Selected examples of biologically active compounds containing the 
pyrazolo[1,5-a]pyridine core 
N N
O
NH
NN
N N
N
N
Cl
Dopamine D4 antagonist
Dopamine D3 antagonist
N N
N(Pr)2
Dopamine D3 agonist
N N
Ph
N
O
HO
Diuretic adenosine A1 antagonist
N N
HN
N
N
F
H
N
Antiherpetic
N N
Ph
N
N
O
Adenosine receptor antagonist
6
1110
87
12
OMe
CO2H
N N
N Me
N
O
H
5HT3 antagonist
9
 
                                                
8 Hansen, J. B.; Weis, J.; Suzdak, P. D.; Eskesen, K. Bioorg. Med. Chem. Lett. 1994, 4, 695. 
9Akahane, A.; Katayama, H.; Mitsunaga, T.; Kato, T.; Kinoshita, T.; Kita, Y.; Kusunoki, T.; Terai, T.; 
Yoshida, K.; Shiokawa, Y. J. Med. Chem. 1999, 42, 779. 
10Kuroda, S.; Akahane, A.; Itani, H.; Nishimura, S.; Durkin, K.; Kinoshita, T.; Tenda, Y.; Sakane, K. Bioorg. 
Med. Chem. Lett. 1999, 9, 1979. 
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Pyrazolo[1,5-a]pyridines are indole and azaindole (pyrrolopyridines) bioisosteres.2 
Considering the metabolic instability of indoles and their high biological relevance, it is no 
surprise that significant efforts have been put forth in the development of pyrazolo[1,5-
a]pyridine derivatives.2  
1.2 Previous syntheses of pyrazolo[1,5-a]pyridines 
Methods for the synthesis of pyrazolo[1,5-a]pyridines will be described in the following 
section and their advantages and drawbacks will be exposed. 
1.2.1 [3 + 2] Cycloaddition reactions 
Few synthetic approaches to the pyrazolo[1,5-a]pyridine backbone are in the literature. The 
most commonly used method for the synthesis of pyrazolo[1,5-a]pyridines in the chemical 
industry today involve a [3 + 2] cycloaddition of N-aminopyridines with alkynoic esters, 
initially developed in the early sixties.6 As outlined in Scheme 1, N-aminopyridinium 13 is 
reacted with alkyne 14 to form a bicyclic intermediate (e.g., 15) which undergoes oxidation 
to form 16.6 The bicyclic ring intermediates most often undergo spontaneous 
rearomatization to afford product 16.6 In some cases, the dehydrogenation of 15 may be 
aided by bubbling air or oxygen into the reaction medium.6 Several ambident synthons of 
both alkynes and alkenes have been explored in the cycloaddition. Some examples are 
summarized in Table 1.11  
Scheme 1: Synthesis of pyrazolo[1,5-a]pyridines through cycloaddition of alkynes with N-
aminopyridinium derivatives 
N
NH2
X EWG
N
H2N
EWG
H
-H2
-HX
N
N
EWG
13 14 15 16
2
3
1
4
5
6
7
8
X
 
                                                
11 Couty, F.; Evano, G., “Bicyclic 5-6 Systems with One Bridgehead (Ring Junction) Nitrogen Atom:  
One Extra Heteroatom 1:0”, In Comprehensive Heterocyclic Chemistry III, Katritzky, A. R.;  
Ramsden, C. A.; Scriven, E. F. V.; Taylor, R. J. K. Eds. Elsevier: Oxford, 2008; Vol. 11, pp. 409.  
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Table 1: Synthesis of pyrazolo[1,5-a]pyridines through cycloaddition of alkynes with N-
aminopyridinium derivatives 
3
4
5
Entry Substates Conditions Products
1
2
N
NH2
MeO
I
OMe
O
17 18
N
NH2
I
O
EtO
2120
Et3N, EtOH
reflux, 5 h
72-80%
K2CO3 
ethylene glycol
DMF, 130 °C
16 h
38%
N
N
OMe
O
19
N
N
O
22
N
NH2
I OMe
O
H
20 23
K2CO3, air-O2
DMF, rt, 1.5 h
72%
N N
CO2Me
24
N
NH2
I OEt
O
Ph
2520
KOH
DMF
32% N N
CO2Et
Ph
26
N
NH2
I
OMe
OMeO
O
2720
K2CO3, air-O2
DMF, rt, 2 h
45%
N N
CO2Me
CO2Me
28
N
NH2MSTS
CNCH2O2Et
29 30
(i-Pr)2EtN
MeCN, reflux 
20 h
61%
N
N
CN
31
N
NH2
I OEt
O
R1
R2
Rf
F F
32 33
K2CO3, NEt3
DMF, 50 °C
5-6 h
54-95%
N N
CO2Et
Rf
R2
R1
34
6
7
Rf= HCF2, CF3, Cl(CF2)3, Cl(CF2)5, F(CF2)7  
Figure 3: Pyrazolo[1,5-a]pyridine numbering system 
35
N N
C-2
C-3
N-1
N-8
C-4
C-5
C-6
C-7  
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A limitation of the reactions shown in Table 1 is the necessity of having an electron 
withdrawing group directly connected to the alkene or alkyne substrate. Consequently, the 
C-3 position (refer to Figure 3) is functionalized in situ with low to moderate yields with 
esters (Table 1, entries 1,3,4,5,7), cyano (entry 6), and carbonyl (entry 2) functionalities. 
Conversely, the C-2 position has been more challenging to functionalize resulting usually 
in poor yield (entries 2,4,5,7). Several therapeutic drugs, such as those discussed in the 
previous section require functionalization of the C-2 position, the modification of which 
has thus been an area of synthetic interest. 
1.2.2 Intramolecular cyclization reactions 
Intramolecular rearrangement reactions have also given rise to the formation of 
pyrazolo[1,5-a]pyridines (Scheme 2).12 Ethynylpyridines 36 were aminated by treatment 
with O-mesitylsulphonylhydroxylamine to form 37 in 70-90% yield. Salt 37 was subjected 
to basic conditions with potassium carbonate to give rise to the intramolecular cyclization. 
The resulting pyrazolo[1,5-a]pyridine, substituted at the C-2 position, was obtained in low 
to excellent yields (depending on the R group). The authors propose a stepwise mechanism, 
because as a concerted mechanism would involve prohibitive ring strain of the five-
membered cyclic allene intermediate.12 The C-2 position of the pyrazolo[1,5-a]pyridine 38 
was functionalized with four different R groups; however, multistep syntheses was required 
to obtain the starting material 36.  
Scheme 2: Intramolecular cyclization of alkynes 
N
R
H2NOMts
70-90% N
R
NH2
MtsO
K2CO3
DMF, rt
15-95%
4 examples
N N
R
36 37 38  
Intramolecular cyclization reactions of transient nitrenes have also given rise to 
pyrazolo[1,5-a]pyridines typically by way of thermolysis of an azido group (Scheme 3).13 
                                                
12 Takashi Tsuchiya, Haruki Sashida, J. S. C. Chem. Comm. 1980, 1109. 
13 Geza Timari, Tibor Soos, Gyorgy Hajos, Andras Messmer, Janos Nacsa, Jozsef Molnar, Bioorg. Med. 
Chem. Lett. Vol. 6, No. 23, 1996, 2831. 
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Albeit, the accessibility of the azido substrate 39 may be limited and requires a multistep 
synthesis, the ring-closing step occurs readily.13 
Scheme 3: Synthesis of pyrazolo[1,5-a]pyridines via the rearrangement of nitrenes 
N N3
heat
-N2 N N N N
68-72%
39 40 41R= H, Cl
R
RR
 
The nitrene has also been formed in situ from the rearrangement of azirine 43, which was 
generated via oxime 42 (Scheme 4).14 Azirine 43 was isolated and found to be remarkably 
stable; however, the reaction from 42 to 44 was typically carried out as a one-pot reaction 
by heating to 180 ºC in 30% yield, albeit with numerous side products.15 Alternatively, 
pyrazole 44 was obtained via iron (II) salt catalysis, which permitted lower temperatures 
and reduced the formation of undesired side products giving 44 in improved yields.15 
Scheme 4: Synthesis of pyrazolo[1,5-a]pyridines via the rearrangement of azirines 
TFAA, Et3N
DCM, 0 °C
N N
N
Cl
N OH
F N
Cl
F
N
FeCl2 
DME, 80 °C
68% for 2 steps Cl
F
42 43 44  
1.2.3 Radical approaches 
New approaches have been reported for the synthesis of pyrazolopyridines involving the 
ring closure of the five-membered pyrazole ring, through a radical cyclization (Scheme 5); 
                                                
14 Stevens, K. L.; Jung, D. K.; Alberti, M. J.; Badiang, J. G.; Peckham, G. E.; Veal, J. M.; Cheung, M.; Harris, 
P. A.; Chamberlain, S. D.; Peel, M. R. Org. Lett. 2005, 7, 4753. 
15 Johns, B. A.; Gudmundsson, K. S.; Turner, E. M.; Allen, S. H.; Jung, D. K.; Sexton, C. J.; Boyd, F. L.; 
Peel, M. R. Tetrahedron 2003, 59, 9001. 
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however, the method suffers from low yields (2-56%) due to competitive reduction of the 
starting material (50).16 
Scheme 5: Synthesis of pyrazolo[1,5-a]pyridines via radical chemistry 
N N N
YBr Z TTMSS, AIBN
K2CO3
2-56% N N N
Y Z
N
Y
Z
N N
N
Y
Z
N N
Y= CH, N
Z= Ph, Cl, Br, H
45 46 47
4849
!H+
N
Y
Z
N N
N
Z
H2N
Reduced product
50
 
1.3 Reactivity of pyrazolo[1,5-a]pyridines 
1.3.1 Introduction 
The reactivity of pyrazolo[1,5-a]pyridines results from a combination of the two ring 
systems (Figure 4), because the ring fusion nitrogen (N-8) contributes to the aromaticity of 
both systems.11 The lone pair of electrons on N-8 may be viewed as “pyrrole-like” because 
it has a low pKa and poor nucleophilicity.11 On the other hand, the N-1 nitrogen may be 
considered “pyridine-like”, because of its greater nucleophilicity.11 The N-1 position is the 
site of protonation.Error! Bookmark not defined. The C-3 position can undergo regioselective 
electrophilic substitution.11 The C-7 hydrogen can be deprotonated when treated with 
strong bases and the resulting anion has been reacted with electrophiles.  
Figure 4: Reactivity of pyrazolo[1,5-a]pyridines 
N N "Pyridine-like"
"Pyrrole-like" 51
Nucleophilic siteC-3
N-1
N-8C-7
 
                                                
16 Nunez, A.; Garcia de Viedna, A.; Martinez-Barrasa, V.; Burgos, C.; Alvarez-Builla, J. Synlett, 2002, 1093. 
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1.3.2 Electrophilic substitution reactions 
Electrophilic substitution reactions at C-3 occur regioselectively (Table 2) and include 
nitrations, halogenations, Friedel Craft acylations (entries 1,2,3)17,9, Vilsmeier-Haack 
formylations (entry 5)18, and Mannich reactions (entry 4 & 6).19 
Table 2: Electrophilic substitution reactions at the C-3 position of pyrazolo[1,5-a]pyridine 
derivatives 
3
Entry Substates Conditions Products
1
2
Br
O
Br
Me
52
N N
53
AlCl3
77%
54
N N
O
Br
N
55
N N
Ph
56
ClCO2Et
then t-BuOK
air
34%
57
N N
Ph
N
N
N
55
N N
Ph
58
ClCO2Et
53%
59
N
N
Ph
N
N
CO2Et
4
5
6
Cl
N
H
O
HN
60
N N
61
CH2O
Et2NMe
AcOH
85%
62
Cl
N
H
O
N
N N
N N
F
F3C
63
POCl3
DMF
94%
64
N N
F
F3C
CHO
HN
N
I
60
N N
65
CH2O
AcOH
42%
66
N
N
I
N
N
 
                                                
17 Yoshida, N.; Aono, M.; Tsubuki, T.; Awano, K.; Kobayashi, T. Tetrahedron Asymmetry 2003, 14, 529. 
18 Allen, S. H.; Johns, B. A.; Gudmundsson, K. S.; Freeman, G. A.; Boyd, F. L.; Secxton, C. H.; Selleseth, D. 
W.; Creech, K. L.; Moniri, K. R. Bioorg. Med. Chem. 2006, 14, 944. 
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1.3.4 Cross-coupling reactions 
The following schemes show a few examples of metal catalyzed coupling reactions of 
pyrazolopyridines, including a Stille vinylation followed by dimerization (68) in good yield 
(Scheme 6).2 
Scheme 6: Stille coupling reactions of 7-iodopyrazolo[1,5-a]pyridine 67 
N N
I
N N
Ph
CH2=CHSnBu3
Pd(PPh3)4
Toluene, reflux
62%
PhSnBu3
Pd(PPh3)4
Toluene, reflux
82%
CH2=CHSnBu3
PdCl2(PPh3)2
NMP, 120 °C
83%
N N
NN
N
N
67
68
69
70
 
7-Iodopyrazolo[1,5-a]pyridine 71 has undergone Suzuki coupling reactions (e.g., 72), 
Sonogashira reactions (e.g., 74), palladium catalyzed coupling reactions (e.g., 75), and 
aminations (e.g., 73) in good to excellent yields (Scheme 7).2  
                                                                                                                                               
19 Lober, S.; Ortner, B.; Bettinetti, L.; Hubner, H.; Gmeiner, P. Tetrahedron: Asymmetry 2002, 13, 2303. 
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Scheme 7: Cross coupling reactions with 7-iodopyrazolo[1,5-a]pyridine 71 
N N
I
N N
CN
TMSC!CH, Pd(PPh3)4, CuI
                       EtNMe2, rt
                             66%
CuCN, Pd2(dba)3
dppf
Dioxane, reflux
95%
4-FC6H5-B(OH)2
Pd(PPh3)4
Toluene, H2O
NaHCO3, reflux
80%
N N
Me
N N
C6H4-4-F
Me
TMS
Me
Me
4-Bn-piperazine, Pd2(dba)3, Na-t-BuO
   toluene, 120 °C              
     50%
N N
N
Me
N
Bn
71 72
7374
75
 
1.3.5 Directed ortho metallation of pyrazolo[1,5-a]pyridine 
The C-7 position of pyrazolopyridine 60 can be deprotonated with a strong base such as n-
BuLi (Scheme 8).20 The resulting anion has been treated with diiodoethane to provide 7-
iodo derivative in 90% yield.2 Similarly, a 7-formyl derivative has been prepared by 
treatment of pyrazolopyridine 60 with n-BuLi followed by ethyl formate in 82% yield.20 
Scheme 8: Ortho directed metallation 
N
N
n-BuLi, ! 78 °C
ICH2CH2I, THF
3.5 h, 90%
N
N
76
N
N
I
67
O
H
60
n-BuLi, ! 78 °C
HCOEt, THF, 82%
 
1.4 Previous work in our group leading to the development of 
pyrazolo[1,5-a]pyridines 
Our group has been interested in the development of novel chemistry for the formation of 
nitrogen containing heterocycles such as piperidines and N-iminopyridinium ylides. 
Nitrogen containing heterocycles are found to be the precursors in many of the syntheses 
                                                
20 Lober, S.; Hubner, H.; Utz, W.; Gmeiner, P. J. Med. Chem. 2001, 44, 2691. 
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affording novel heterocyclic compounds. In this section, the chemistry developed in our 
group leading to the development for the synthesis of pyrazolo[1,5-a]pyridines will be 
presented chronologically. 
1.4.1 Synthesis of N-iminopyridinium ylide derivatives 
To access N-substituted-iminopyridinium ylides, several aminating agents have been 
examined (Figure 5).21 Hydroxylamine-O-sulfonic acid 79 has been broadly applied albeit 
with moderate yields and need for excess pyridine.21 A frequently used aminating reagent is 
O-mesitylenesulfonylhydroxylamine 80, in spite of its high cost and instability.21 O-
mesitylenesulfonylhydroxylamine 80 rapidly decomposes at room temperature and has 
associated explosion risk even when stored below 0 ºC hence it is recommended to prepare 
freshly before use. Our attention turned to O-(2,4-dinitrophenyl)hydroxylamine 84, because 
it is more stable than O-mesitylenesulfonylhydroxylamine 80 and because it was previously 
used to make N-iminopyridinium ylides in comparitavely good yields.21 
Figure 5: Aminating reagents 
S
OO
HO O
NH2
S
O
O O
H2N
O2N
O NO2
H2N
79 80 84  
O-(2,4-dinitrophenyl)hydroxylamine 84 was previously synthesized from N-Boc 
hydroxylamine and chloro- or fluoro-2,4-dinitrobenzene.21 Our group developed a new, 
cost effective procedure for synthesizing aminating reagent 84 in excellent yield without 
purification (Scheme 9), from N,O-dinitrosubstituted product 83.21  
Scheme 9: O-(2,4-dinitrophenyl)hydroxylamine synthesis 
NO O
OH
1. Et3N (1 equiv)
2. 2,4-dinitrochlorobenzene
Acetone, rt, 2 h
95%
NO O
O
O2N NO2
85 83
NH2NH2•H2O (2 equiv)
DCM:MeOH (8:1)
0 °C, 8 h
99% ONH2
NO2
O2N
84
 
                                                
21 Legault, C.; Charette, A. B. J. Org. Chem. 2003, 68, 7119. 
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O-Aryl hydroxyl-N-phthalimide 83 was synthesized from N-hydroxyphthalimide 85 by 
nucleophilic aromatic substitution of chloro-2,4-dinitrobenzene by nucleophilic attack of N-
hydroxyphthalamide in the presence of triethylamine and acetone in excellent yield without 
purification (Scheme 9).21 Hydroxylamine 84 was obtained by mild hydrazinolysis of O-
Aryl hydroxyl-N-phthalimide 83. 
With 83 in hand, the synthesis of a variety of pyridinium ylides were carried out as one-pot 
reactions.20 The optimal conditions for the transformation was found to be a 1:1 mixture of 
THF and water at 40 ºC for 12 hours.21 The reaction was then diluted with sodium 
hydroxide and treated with 50% excess benzoyl chloride giving rise to the corresponding 
N-iminopyridinium ylides in 43-99% yield (Scheme 10) starting from the pyridine 
derivative.21  
Scheme 10: Synthesis of N-benzoyliminopyridinium ylide derivatives 
N
NBz
N
i) 84 (1.2 equiv)
   THF:H2O (1:1)
   40 °C, 12 h
ii) PhCOCl (1.5 equiv)
    NaOH 10 %, rt, 4 h
R
R
11 examples
43-99% yield
87
88  
1.4.2 Grignard addition onto N-iminopyridinium ylides 
Piperidines are subunits present in many natural products and biologically active 
compounds.23 A method to obtain piperidine derivatives has used addition reactions of 
nucleophiles onto activated pyridine moieties; however, such reactions are usually not 
regioselective, such that protecting groups have been used to block undesired electrophilic 
sites.22 Furthermore, directing groups have been employed to control the site of addition.22 
N-Iminopyridinium ylide 89 was explored in addition reactions, because the benzoyl group 
could act as both a Lewis base to activate organometallic nucleophiles as well as a directing 
group to control regioselectivity (Scheme 11).22  
                                                
22 Legault, C.; Charette, A. B. J. Am. Chem. Soc. 2003, 125, 6360. 
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Scheme 11: Directed organometallic addition reaction 
N
NBz
Complexation Addition
N
NBz
R
M
89 90 91
N
NO
M
R
 
Several Grignard reagents were tested in reactions with 89 and the intermediate, were 
reduced in situ with NaBH4 to obtain 1,2,5,6-tetrahydropyridines in 71-91% yield and high 
regioselectivity (typically >95/5) (Scheme 12).22 
Scheme 12: Formation of 1,2,5,6-tetrahydropyridines  
N
NBz
1. RMgX, CH2Cl2
    rt, 25 min
2. NaBH4, MeOH
N
N
R
NHBz
R
NHBz
89 93 94
yield: 71-91%
9 examples
major minor  
The same methodology was applied to 2-methyl-substituted pyridine and demonstrated 
complete regioselectivity favoring the 1,2-adduct.22 Upon reduction of the intermediate 
dihydropyridine, the cis isomer 96 was favoured in all cases in moderate to excellent 
diastereoselectivities and in high yields (Table 3).22  
Table 3: Formation of 2,6-disubstituted-1,2,5,6-tetrahydropyridines 
N
NBz
1. RMgX, CH2Cl2
    rt, 40 min
2. NaBH4, AcOH
    !78 °C, 90 min
N
R
NHBz
95 96
N
R
NHBz
97major minor
Entry Combined yield96/97
1 78
RMgX
MeMgBr
n-PrMgCl
i-PrMgBr
69/31
81/19
>95/5
85
84
2
3  
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1.4.3 Palladium-catalyzed direct arylation of N-iminopyridinium ylides 
Acyl pyridines have been made by cross-coupling reactions between 2-halopyridines and 
aryl organometallic derivatives, as well as by aryl-Grignard additions to pyridine N-
oxides.23 The main drawback of these methods is the use of stoichiometric amounts of 
organometallic reagent which recently been remedied using palladium-catalyzed direct C-H 
arylation of N-iminopyridinium ylides.23 Although few direct arylations of pyridine 
derivatives have been reported.23 Arylation using aryl and heteroaryl bromides with N-
iminopyridinium ylides was achieved both with excellent selectivities and good yields 
(Scheme 13).23 Electron rich and electron poor aryl bromides were compatible, albeit 
electron poor aryl bromides required 2.5 rather than 1.5 equivalents of the ylide.23 
Scheme 13: Palladium-catalyzed arylation of N-iminopyridinium ylides 
N
NBz
Pd(OAc)2 (5 mol %)
P(tBu)3 (15 mol %), K2CO3 (3 equiv)
M.S. 3 Å, toluene 125 ºC 16-20 h
98
N
NBz
99
R yield: 50-83%
16 examplesR
+
89
1 equiv.1.5 equiv.
 
Substituted N-iminopyridinium ylides usually gave lower yields than unsubstituted ylides 
and required the use of excess aryl bromides. The 3-methyl-N-iminopyridinium ylide when 
reacted with aryl bromide gave a 10:1 ratio favouring 2,5-disubstituted adducts.23 
After N-alkylation, it was possible to cleave the N-N bond of the arylated N-
iminopyridinium ylides via three different methods in good yield as depicted in Scheme 
14.23 
                                                
23 Larivée, A.; Mousseau, J. J.; Charette, A. B. J. Am. Chem. Soc. 2008, 130, 52. 
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Scheme 14: Reductive cleavage of the N-N bond 
N
N
Ph
O
MeI, acetone
75 °C, quant.
N
NMe
Ph
Ph
O
I
Zn (dust), AcOH, rt
80%
HCO2NH4, Pt/C, MeOH, 80 °C
83%
TMS3SiH, AIBN, toluene, 80 °C
85%
Ph
N Ph
100 101 102
 
1.4.4 Copper-catalyzed direct alkenylation of N-iminopyridinium ylides 
Following the results for the direct arylation, our group explored the alkenylation of N-
iminopyridinium ylides. Little was known on direct alkenylation reactions, especially those 
of heteroaryl compounds.24 Although, most literature precedents had used palladium, 
rhodium, and ruthenium to catalyze such reactions, our group explored copper and iron 
catalysis due to their relatively low cost and toxicity.24  
The copper-catalyzed reaction was successful, and gave better yields compared to the 
palladium-catalyzed alkenylation.24  
Scheme 15: Palladium-catalyzed alkenylation 
N
NBz
Pd(OAc)2 (5 mol %), 
P(tBu)3 (15 mol %), K2CO3 (3 equiv)
toluene 125 ºC 16-20 h
89
N
NBz
104
I yield: 36%
103
The scope of the copper-catalyzed direct alkenylation reaction (Table 4) was quite general, 
tolerating phenyl and sterically hindered bis-vinyl iodides.24 Good to excellent yields were 
obtained for both electron rich and electron poor substrates.24 Furthermore, the reaction was 
chemoselective, reacting selectively on the alkenyl iodide (no arylated product was 
obtained for the halo-substituted styryl iodides).24 
                                                
24 Mousseau, J. J.; Bull J. A.; Charette, A. B. Angew. Chem. Int. Ed. 2010, 49, 1115. 
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Table 4: Copper-catalyzed direct alkenylation of N-iminopyridinium ylides 
Alkenyl iodide Products
103
N
N
NBz
H
+
N
NBz
CuBr2 (10 mol%)
K2CO3 (2 equiv)
PhCl (0.2 M), 125 ºC, 
16-24 h
1.5 equiv 1 equiv
R
I
R
R' R'
105 106 107
I
NBz
78%104
108
I
N
NBz
81%109
110
I
N
NBz
78%111
112
I
N
NBz
48%113
114
I I
N
NBz
N
NBz
63%115
116 117
I
OMe
87%
N
NBz
OMe
N
NBz
BnO
I
BnO
71%119118
I
MeO
N
NBz
MeO
93%121120
I
O
O
N
NBz O
O
75%123122
I
CF3
N
NBz
CF3
71%125124
N
NBz
CN
I
CN
89%127126
N
NBz
F
I
F
83%129128
I
Cl
N
NBz
Cl
74%131130
I
Br
N
NBz
Br
65%133132
I
Br
N
NBz
Br
74%135134
I
I
N
NBz
I
47%137136
I I
N
NBz
I
41%139138
I
Ph
N
NBz Ph
53%141140
I
N
NBz
52%143142
I
OPMB
N
NBz OPMB
30%145144
Alkenyl iodide Products
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1.4.5  Pyrazolo[1,5-a]pyridines 
During the optimization studies for the alkenylation of N-iminopyridinium ylides, our 
group discovered that a significant amount of pyrazolo[1,5-a]pyridine was obtained when a 
silver base was used under palladium catalysis (Scheme 16). 
Scheme 16: Palladium-catalyzed direct alkenylation of N-iminopyridinium ylides with and 
without a silver base 
N
NBz
Ph
I
Pd catalyzed
N
NBz
PhN
N
Ph
Pd catalyzed
55 89 146 147
Ag2CO3 K2CO3
 
Knowing that pyrazolo[1,5-a]pyridines are biologically important and are difficult to 
prepare, we turned our attention to further developing the methodology. The syntheses of 
3-substituted pyrazolo[1,5-a]pyridines have been previously described by other groups with 
moderate to good yields, as seen earlier in this chapter. 2-Substituted pyrazolo[1,5-
a]pyridines have, however been less successfully synthesized due to low yields and 
relatively expensive starting materials. Encouraged by our earlier findings23, we decided to 
optimize the reaction conditions to develop a general approach to synthesize 2-substituted 
pyrazolo[1,5-a]pyridines. 
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Chapter 2: Synthesis of 2-pyrazolo[1,5-a]pyridines  
2.1 Introduction 
During the optimization of the alkenylation of N-iminopyridinium ylides, we discovered 
that use of silver carbonate instead of potassium carbonate gave 45% (1H NMR yield) of 2-
phenylpyrazolo[1,5-a]pyridine 55 instead of alkenylated ylide 147 (Scheme 17). Reaction 
conversions were assessed after filtering crude material through a small pad of silica gel 
eluting with dichloromethane and solvent evaporation by 1H NMR spectroscopy of the 
crude materials using an internal standard (1,3,5-trimethoxy benzene). The spectra revealed 
complete consumption of the styryl iodide reagent in all reactions after 16 hours. No vinyl 
pyridinium 147 was formed in all cases using a silver base. 
Scheme 17: Palladium-catalyzed reactions of potassium carbonate versus silver carbonate 
between N-iminopyridinium ylides and styryl iodides 
N
NBz
Ph
I
Pd(OAc)2 (5 mol %), P(t-Bu)3 (15 mol %), 
K2CO3 (3 equiv)
toluene, 125 °C, 17 h
50%
N
NBz
Ph
N
N
Ph
Pd(OAc)2 (5 mol %), P(t-Bu)3 (15 mol %), 
Ag2CO3 (3 equiv)
toluene, 125 °C, 17 h
45% 1H NMR yield
N
NBz
Ph
I
89 146
14689 55
147
 
2.2 Optimization of the reagents 
2.2.1 Examination of the silver source 
The formation of 2-phenylpyrazolo[1,5-a]pyridine 55 occurred using of a silver base and 
palladium catalysis. A wide variety of silver sources were tested in the presence and 
absence of potassium carbonate under the same alkenylation reaction conditions (Table 5).  
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Table 5: Screening of silver salts 
N
NBz
I
Ph
N
N
"Silver source" (3 equiv), "base" (3 equiv)
Pd(OAc)2 (0.05 equiv), P(t-Bu)3 (0.15 equiv)
toluene, 125 °C, 16 h
Ph(1.5 equiv) (1 equiv)
89 146 55  
Entry Silver source Base 1H NMR Yields 
1           — K2CO3 0% 
2 AgSbF6 - 0% 
3 AgSbF6 K2CO3 0% 
4 AgBF4 - 0% 
5 AgBF4 K2CO3 0% 
6 AgPF6 - 0% 
7 AgPF6 K2CO3 0% 
8 Ag2SO4 - 0% 
9 Ag2SO4 K2CO3 4% 
10 Ag3PO4 - 9% 
11 Ag3PO4 K2CO3 5% 
12 AgOTf - 0% 
13 AgOTf K2CO3 0% 
14 AgTFA - 0% 
15 AgTFA K2CO3 16% 
16 Ag2O - 25% 
17 Ag2O K2CO3 0% 
18 AgOAc - 13% 
19 AgOAc K2CO3 21% 
20 Ag2CO3 - 45% 
21 Ag2CO3 K2CO3 50% 
22 AgOBz - 51% 
23 AgOBz K2CO3 51% 
 
Although most silver sources did not form the desired product, 2-phenylpyrazolo[1,5-
a]pyridine 55 was obtained with silver carbonate (50% conversion, entry 20), and silver 
benzoate (51% conversion, entry 22). Carboxylate counterions favored the reaction. 
Several groups have proposed transition states for palladium-catalyzed C-H insertions that 
exploit carboxylates onto aromatic substrates (Figure 7).25  
                                                
25 (a) Davies, D. L.; Donald, S. M. A.; Macgregor, S. A. J. Am. Chem. Soc. 2005, 127, 13754. (b) Garcia-
Cuadrado, D.; Braga, A. A. C.; Maseras, F.; Echavarren, A. M. J. Am. Chem. Soc. 2006, 128, 1066. (c) 
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Figure 6: Proposed transition states for carboxylate-assisted palladation of arenes24 
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We may apply a similar transition state to explain the alkynylation of N-iminopyridinium 
ylides (Scheme 18) with the silver carboxylates (e.g., 154-156).  
Scheme 18: Plausible transition states of N-iminopyridinium ylides with silver 
carboxylates 
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Garcia-Cuadrado, D.; de Mendoza, P.; Braga, A. A. C.; Maseras, F.; Echavarren, A. M. J. Am.Chem. Soc. 
2007, 129, 6880. (d) Biswas, B.; Sugimoto, M.; Sakaki, S. Organometallics 2000, 19, 3895. (e) Lafrance, M.; 
Rowley, C. N.; Woo, T. K.; Fagnou, K. J. Am. Chem. Soc. 2006, 128, 8754. (f) Lafrance, M.; Fagnou, K. J. 
Am. Chem. Soc. 2006, 128, 16496. (g) Lafrance, M.; Lapointe, D.; Fagnou, K. Tetrahedron 2008, 64, 6015. 
 
 22 
Further optimization studies were performed without the addition of an additional base, 
because the addition of potassium carbonate gave only a slight improvement in yield in 
some cases (Table 5).  
Alkenylation of N-iminopyridinium ylide 89, was also obtained using copper bromide as 
catalyst with silver carbonate to furnish cyclized product 55 in 20% yield (Table 6).24  
Table 6: Copper bromide-catalyzed synthesis of pyrazolo[1,5-a]pyridine 
N
NBz
I
Ph N
N
CuBr (0.15 equiv)
"silver source" (3 equiv), P(t-Bu)3 (0.15 equiv)
"solvent", 125 °C, 16 h
Ph(1.5 equiv) (1 equiv)
89 146 55  
Entry Silver source Solvent 1H NMR Yields 
1 Ag2CO3 Toluene 20% 
2 AgOBz Toluene 0% 
3 Ag2CO3 THF 0% 
 
Although Padwa had shown that gold could be used with success in C-H 
insertion/cyclization type reactions, no 2-phenylpyrazolo[1,5-a]pyridine was obtained on 
replacement of the silver source for a gold source.26   
2.2.2 Examination of the palladium source 
We investigated next the palladium source in the presence of silver benzoate (Table 7). The 
palladium counterion had a limited role in the reaction and palladium bromide, acetate and 
iodide gave 55, 52 and 46% yields, respectively. 
                                                
26 Verniest, G.; Padwa, A. Org. Lett. 2008, Vol. 10, No. 19, 4379. 
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Table 7: Screening of palladium salts 
N
NBz
I
Ph N
N
Ph(1.5 equiv) (1 equiv)
89 146 55
"Palladium source" (0.05 equiv)
 AgOBz (3 equiv), P(t-Bu)3 (0.15 equiv)
toluene, 125 °C, 16 h
 
Entry Palladium source 1H NMR Yields 
1 Pd(dba)3 31% 
2 Pd(TFA)2 36% 
3 Pd(dba)2 40% 
4 PdCl2(NCPh)2 45% 
5 PdI2 46% 
6 Pd(OAc)2 52% 
7 PdBr2 55% 
 
2.2.3 Examination of ligand 
Phosphine ligands were investigated using palladium acetate (Table 6) and palladium 
bromide (Table 8), with yields ranging from 37-63%, and best results (63% yield) with tris-
4-methoxyphenylphosphine and palladium bromide (Table 9, entry 15). 
Table 8: Ligand screening with palladium acetate 
N
NBz
I
Ph N
N
Ph(1.5 equiv) (1 equiv)
89 146 55
AgOBz (3 equiv), "ligand" (0.15 equiv)
Pd(OAc)2 (0.05 equiv)
toluene, 125 °C, 16 h
 
Entry Ligand 1H NMR Yields 
1 DAVE PHOS 37% 
2 (R,R)-DIOP 41% 
3 Bn PHOS 44% 
4 Pt-Bu3 46% 
5 Ru PHOS 47% 
6 P(Cy)3 50% 
7 2-(Di-t-BuP)biPh 51% 
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Table 9: Ligand screening with palladium bromide 
N
NBz
I
Ph N
N
Ph(1.5 equiv) (1 equiv)
89 146 55
AgOBz (3 equiv), "ligand" (0.15 equiv)
PdBr2 (0.05 equiv)
toluene, 125 °C, 16 h
 
Entry Ligand 1H NMR Yields 
8 P(2,4,6-tri(MeO)Ph)3 54% 
9 PPh3 59% 
10 P(2-MePh)3 60% 
11 (±)-BINAP 61% 
12 (R)-BINAPHANE 62% 
13 (R)-(+)-2-[2-(Ph2P)Ph]-4-iPr-2-oxazoline 62% 
14 P(n-Bu)3 62% 
15 P(4-MeOPh)3 63% 
 
2.2.4 Examination of preformed palladium complexes 
Preformed phosphine complexes of palladium were also screened (Table 10) giving 32-
58% yields. 
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Table 10: Palladium complex screening 
N
NBz
I
Ph N
N
Ph(1.5 equiv) (1 equiv)
89 146 55
"Palladium source" (0.05 equiv)
 AgOBz (3 equiv)
toluene, 125 °C, 16 h
 
Entry Palladium source 1H NMR Yields 
1 Pd(dppf)2Cl2•CH2Cl2 32% 
2 Pd(iMes)-Napquin dimer 37% 
3 Pd(t-Bu3P)2 47% 
4 (PCy3)2PdCl2 47% 
5 (PPh3)2Pd(OAc)2 53% 
6 PEPPSI 54% 
7 Pd(PPh3)4 58% 
 
2.2.5 Examination of solvent 
Different solvents were tested in a sealed tube at 125 ºC, which was slightly above certain 
solvent reflux temperatures (Table 11). Dimethoxyethane (DME) and dioxane gave 
similarly good yields (71 and 69%, respectively).  
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Table 11: Screening of solvent for the synthesis of pyrazolo[1,5-a]pyridines 
N
NBz
I
Ph N
N
Ph(1.5 equiv) (1 equiv)
89 146 55
AgOBz (3 equiv), P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
"solvent", 125 °C, 16 h
 
Entry Solvent 1H NMR Yield 
1 DCE 28% 
2 DMF 46% 
3 Chlorobenzene 54% 
4 Toluene 60% 
5 MeCN 62% 
6 THF 64% 
7 NMP 68% 
8 Dioxane 69% 
9 DME 71% 
 
2.3 Examination of the stoichiometry 
2.3.1 Styryl iodide to ylide ratio 
As the ylide to styryl iodide ratio increased, the yield of pyrazolo[1,5-a]pyridine 55 
increased (Table 12). Unreacted ylide could be recovered; however, we opted to use of two 
equivalents. 
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Table 12: Examination of varying the styryl iodide to ylide ratios 
N
NBz
I
Ph N
N
Ph(x equiv) (1 equiv)
89 146 55
AgOBz (3 equiv), P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane (0.2 M), 125 °C, 16 h
 
Entry Ylide (equiv) 1H NMR Yields 
1 0.50 68% 
2 0.75 60% 
3 1.00 63% 
4 1.25 69% 
5 1.50 74% 
6 2.00 80% 
7 3.00 81% 
8 4.00 84% 
 
2.3.2 Examination of concentration 
The concentration of the reaction played limited role in the reaction (Table 13) and yield 
ranged from 52-74% as concentration changed from 0.05 to 1M. A reaction concentration 
of 0.2 molar gave 74% yield of 2-phenylpyrazolo[1,5-a]pyridine (55). 
Table 13: Optimization of the reaction by varying the concentration of dioxane 
N
NBz
I
Ph N
N
Ph(2 equiv) (1 equiv)
89 146 55
AgOBz (3 equiv), P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane, 125 °C, 16 h
 
Entry [Dioxane] (M) 1H NMR Yield 
1 0.05  67% 
2 0.10  64% 
3 0.20  74% 
4 0.40  70% 
5 0.60  52% 
6 0.80  55% 
7 1.00  53% 
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2.3.3 Examination of the mol% of silver  
As the number of equivalents of silver benzoate increased from 1-3, the yield 2-
phenylpyrazolo[1,5-a]pyridine (55) increased from 20-79%. Four equivalents of silver 
benzoate gave a drop in yield (Table 14) likely to silver benzoate’s lack of solubility 
resulting in a heterogeneous mixture, which was more difficult to stir efficiently.  
Table 14: Optimization of the reaction by varying the silver benzoate loading 
N
NBz
I
Ph N
N
Ph(2 equiv) (1 equiv)
89 146 55
AgOBz (x equiv), P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane, 125 °C, 16 h
 
Entry AgOBz (equiv) 1H NMR conversion 
1 1 20% 
2 2 47% 
3 3 79% 
4 4 73% 
 
2.3.4 Palladium to ligand ratio 
The yield of the reaction improved slightly as the ratio of ligand to palladium was 
increased, reaching a plateau of 80% conversion at three to one equivalents (Table 15).  
Table 15: Examination of varying the palladium bromide to ligand ratio 
N
NBz
I
Ph N
N
Ph(2 equiv) (1 equiv)
89 146 55
AgOBz (3 equiv), P(4-MeOPh)3 (x equiv)
PdBr2 (0.05 equiv)
dioxane, 125 °C, 16 h
 
Entry Ligand to Palladium ratio 1H NMR Yields 
1 0 : 1 63% 
2 1 : 1 67% 
3 2 : 1 74% 
4 3 : 1 80% 
5 4 : 1 80% 
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2.3.5 Examination of the mol% of palladium  
Keeping the ligand to palladium ratio at 3:1, best results were obtained with five mol 
percent palladium (80% yield). Palladium was necessary for the C-H insertion to occur.  
Table 16: Examination of the palladium loading 
N
NBz
I
Ph N
N
Ph(2 equiv) (1 equiv)
89 146 55
AgOBz (3 equiv), P(4-MeOPh)3 (y equiv)
PdBr2 (x equiv)
dioxane, 125 °C, 16 h
 
Entry PdBr2 : ligand (equiv) 1H NMR Yield 
1 0.00 : 0.00 0% 
2 0.03 : 0.09 74% 
3 0.05 : 0.15 80% 
4 0.10 : 0.30 65% 
 
2.4 Optimization of the reaction time and temperature 
2.4.1 Optimization of the reaction temperature 
The optimal temperature for the reaction was shown to be 125 ºC (Table 17, entry 4). 
Temperature affected the success of the reaction: below reflux, product was obtained in 
40% yield (entry 1), probably due to an insufficient amount of thermal energy required to 
perform the C-H insertion/cyclization; above 100 ºC, the reaction proceeded in 68-78% 
yields (entries 3,4,5); at 135 ºC, the yield decreased, due to more side reactions. 
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Table 17: Optimization of the reaction by varying the temperature 
N
NBz
I
Ph N
N
Ph(2 equiv) (1 equiv)
89 146 55
AgOBz (3 equiv), P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane, "temperature", 16 h
 
Entry Temperature (°C) 1H NMR Yield 
1 95 40% 
2 100 62% 
3 110 68% 
4 125 78% 
5 135 69% 
  
2.4.1 Optimization of the reaction time 
The reaction is relatively fast, with 50% conversion to 55 after two hours (Table 18, entry 
4). After 16 hours, 80% of the cyclized product was obtained.  
Table 18: Optimization of the reaction by varying the reaction time 
N
NBz
I
Ph N
N
Ph(2 equiv) (1 equiv)
89 146 55
AgOBz (3 equiv), P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane, 125 °C, "time"
 
Entry Time (h) 1H NMR Yield 
1 0.5  12% 
2 1.0 30% 
3 1.5 38% 
4 2.0 50% 
5 5.0 61% 
6 8.0 64% 
7 16 80% 
 
The reaction slows down significantly after the first two hours, probably because of styryl 
iodide decomposition. Styryl iodide is unstable in the presence of light and decomposes at 
room temperature. At the 8-hour mark, little styryl iodide remained and 1H NMR detected 
 31 
none after 16 hours. The increase in the yield from 8 hours to 16 hours may suggest that 
the styryl iodide is complexed with silver and not completely decomposed. 
2.5 Optimal reaction conditions 
2.5.1 Optimization of the reaction conditions 
The optimal reaction conditions for the C-H insertion/cyclization gave 2-
phenylpyrazolo[1,5-a]pyridine in 80% yield (Scheme 19). 
Scheme 19: Optimal reaction conditions for the synthesis of 2-phenylpyrazolo[1,5-
a]pyridine 
N
NBz
I
Ph N
N
Ph(2 equiv) (1 equiv)
89 146 55
AgOBz (3 equiv), P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16h
 
2.5.2 Optimization of the workup for the scope of the reaction 
1H NMR analysis of the crude reaction of the styryl iodide 146 and N-iminopyridinium 
ylide 89 under optimized conditions (dioxane, 125 °C, 3 equivalents of AgOBz, 15 mol% 
of ligand and 5 mol% of PdBr2) showed formation of 55 with few impurities; however, a 
significant amount of benzoic acid was present. The benzoic acid could not be efficiently 
removed by column chromatography since it eluted alongside the products. Hence the 
crude mixture was washed with sodium bicarbonate twice to remove the benzoic acid, prior 
to column chromatography (eluting with 100% dichloromethane), to give spectroscopically 
pure 55 (see chapter 6 for further details). 
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Chapter 3: Scope of the reaction 
3.1 Introduction 
3.1.1 Styryl iodide starting materials 
In recent years, the emergence of metal-catalyzed cross-coupling reactions has given rise to 
the development of new and more efficient methodologies for the formation of aryl and 
vinyl halides. Many of these compounds are commercially available, although not always 
in stereochemically pure form. Several methods exist for the preparation of vinyl halides; 
however, they often suffer from drawbacks.27 Commonly used methods include the Takai-
Utimoto reaction,28,29 the Hunsdiecker reaction,27 the stereoselective reductive removal of a 
halide from a 1,1-dihaloalkene,30 the trapping of a vinyl metal species with an electrophilic 
source where the E-stereochemistry is installed by a cross-metathesis reaction with vinyl 
boronate,31,32 or by hydrometalation of an alkyne.33  
Our group developed a novel method for the synthesis of these useful vinyl halide 
precursors in high yields and E-selectivity.34 In this sub-section, we will briefly show the 
development and scope of the reaction for said compounds.  
                                                
27 For recent examples: (a) Kuang, C.; Yang, Q.; Senboku, H.; Tokuda, M. Synthesis 2005, 1319. (b) You, H.-
W.; Lee, K.-J. Synlett. 2001, 105. (c) Das, J. P.; Roy. S. J. Org. Chem. 2002, 67, 7861. (d) Kuang, C.; 
Senboku, H.; Tokuda, M. Tetrahedron 2005, 61, 637. 
28 Takai, K.; Nitta, K.; Utimoto, K. J. Am. Chem. Soc. 1986, 108, 7408. 
29 Takai, K.; Ichiguchi, T.; Hikasa, S. Synlett. 1999, 1268. 
30 (a) Hirao, T.; Masunaga, T.; Ohshiro, Y.; Agawa, T. J. Org. Chem. 1981, 46, 3745. (b) Kuang, C.; 
Senboku, H.; Tokuda, M. Tetrahedron 2002, 58, 1491. (c) Wang, L.; Li, P.; Xie, Y.; Ding, Y.  Synlett, 2003, 
1137. d) Horibe, H.; Kondo, K.; Okuno, H.; Aoyama, T. Synthesis 2004, 986. 
31 Morrill, C.; Grubbs, R. H J. Org. Chem. 2003, 68, 6031. 
32 For I-Si exchange from (E)-vinyl silanes, see: Barluenga, J.; Alvarez-Garcia, L. J.; Gonzalez, J. M. 
Tetrahedron Lett. 1995, 36, 2153. 
33 (a) Brown, H. C.; Hamaoka, T.; Ravindran, N.; Subrahmanyam, C.; Somayaji, V.; Bhat, N. G. J. Org. 
Chem. 1989, 54, 6075. (b) Masuda, Y.; Hoshi, M.; Arase, A. J. Chem. Soc. Perkin Trans. 1 1992, 2725. 
34 Bull, J. A.; Mousseau, J. J.; Charette, A. B. Org. Lett. 2008, 10, 5485. 
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3.1.2  Preparation of (E)-β-styryl iodides from benzyl bromides and diiodomethane 
(E)-β-Aryl vinyl halides 158 were obtained by a one-pot synthesis starting from benzyl 
bromides 157.34 Under the reaction conditions (Scheme 20), the sodium diiodomethane 
anion was preformed at –78 ºC and added to the benzyl bromide.34 Homologation of 157 
followed by elimination of HI gave rise to E-β-iodostyrene (158).34 Stereoselectivity was 
achieved through minimization of unfavorable steric interactions in the transition state of 
the final elimination.34  
Scheme 20: Optimal reaction conditions for the synthesis (E)−β-styryl iodides 
Br
I
BnBr
THF, –78 ºC to rt
DBU, rt
1.
2.
3.
NaHMDS, CH2I2
THF/ether, –78 ºC RR
157 158  
3.1.3 Scope of (E)-β-styryl iodides 
The yields obtained for the reaction ranged from 63% to 95% and in ≥97:3 E to Z 
selectitivity (Table 19).34 Noteworthy, the synthesis of (E)-(2-iodovinyl)benzene was 
scaled to 30 mmol in 85% yield.34 For more sensitive substrates, the NaHMDS base was 
replaced for the less basic LiCHI2.34 The E-selectivity was slightly greater using NaHMDS 
than with LiCHI2.34  
The reaction tolerated electron withdrawing as well as electron donating substituents on the 
arene; however, a slight decrease in yield occurred with electron-poor substrates.34 
Generally, electron-rich substituents required excess base to ensure complete elimination of 
the diiodide (Table 19).34 In the presence of electron withdrawing groups, milder reaction 
conditions were employed using 2 equivalent of both LiHMDS and CH2I2 instead of 3 
equivalents of NaHMDS and 1.5 equivalent of CH2I2 (Table 19 and 20).34 
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Table 19: Scope of (E)-(2-iodovinyl)benzene derivatives using NaHMDS34 
I
Me
I
Me
I
I
MeO
I
MeO I
O
O
I
I
F
I
Cl
92%
93%
90%
70%
92%
95%
93%
85%
78%
1
2
3
4
5
Entry Benzyl bromide Product Yield
MeO
Br
Br
Br
Br
Br
Me
Me
MeO
Br
Br
Cl
Br
F
O
O
Br
6
7
8
9
Br
I
CH2I2 (1.5 equiv)
NaHMDS (3 equiv)
[0.2 M], !78 ºC to rt, 16 h
DBU (1 equiv) for 1 h
R R
E:Z ratio
98:2
99:1
99:1
98:2
97:3
99:1
98:2
98:2
99:1
157 158
159
160
162
164
165
166
168
169
170 122
128
130
167
116
108
163
161
103
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Table 20: Scope of (E)-(2-iodovinyl)benzene derivatives using LiHMDS34 
157 158
I
I
NC
I
F3C
I
Br
IBr
I
Br
I
I
76%
51%
63%
87%
87%
87%
73%
BnO
1
2
3
4
5
Entry Benzyl bromide Product Yield
6
7
Br
I
CH2I2 (2 equiv)
LiHMDS (2 equiv)
[0.2 M], !78 ºC to rt, 16 h
DBU (2 equiv) for 1 h
R R
Br
Br
NC
Br
F3C
Br
Br
Br
Br
Br
Br
Br
I
BnO
E:Z ratio
98:2
99:1
99:1
99:1
99:1
99:1
98:2
171
172
173
174
175
177
178
132
134
124
126
176
136
179  
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3.1.4 Preparation of (E)-β-styryl halides  
The method was extended to the synthesis of (E)-β-aryl vinyl chlorides and bromides.34 
Both high yields and excellent E-stereoselectivities were achieved using ICH2Cl (Table 21) 
and CH2Br2 (Table 21), respectively.34 For the formation of these products, addition of 
DBU was not necessary as complete elimination to the corresponding vinyl halides was 
achieved in all cases using an excess of NaHMDS.34 LiHMDS could be used in the chloro 
reactions to increase the yield, however the E-selectivity was negatively affected.34 
Table 21: Scope of (E)-β-Styryl chloride derivatives 
1
2
3
4
5
Entry Benzyl bromide Product Yield
MeO
Br
Cl
Br
Br
Br
Br
Br
Br
Cl
ICH2Cl (1.5 equiv)
NaHMDS (3 equiv)
[0.2 M], !78 ºC to rt, 16 h
R R
Cl
Cl
Me
89%
85%
MeO
Cl
88%
Cl
Cl
55%
Cl
Br
55%
Me
E:Z ratio
97:3
>99:1
>99:1
97:3
96:4
157 180
159
168
172
162
165
181
182
183
184
185
 
For vinyl bromides, slight modifications of the reaction conditions were required as 
byproducts were formed. Allowing a longer reaction time (from 16 h to 19 h) minimized 
these byproducts, while increasing the dibromomethane loading decreased their formation 
(Table 22).34 
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Table 22: Scope of (E)-β-styryl bromide derivatives 
157 186
1
2
3
4
5
Entry Benzyl bromide Product Yield
Br
Br
CH2Br2 (4 equiv)
NaHMDS (3 equiv)
[0.2 M], !78 ºC to rt, 19 h
R R
Br
69%
Me
Br
91%
MeO
Br
72%
Br
F
79%
Br
Br
67%
Me
MeO
F
Br
Br
Br
Br
Br
Br
E:Z ratio
99:1
>99:1
>99:1
>99:1
>99:1
159
171
169
160
165
187
188
189
190
191
 
3.2 N-Benzoyliminopyridinium ylide starting material 
As described in Chapter 1, our group developed an effective aminating methodology (Table 
23). With this method in hand, we synthesized a wide variety of N-benzoyliminopyridinium 
ylides.21 The yields of the reaction greatly varied according to the pyridine substituents. 
When the pyridine was substituted with methyl groups, the methodology worked quite 
well, resulting in excellent yields (93-99%) as seen in Table 23.21 High yields were also 
achieved with 2,4-dimethylated pyridines (93%, entry 4) and 2,6-dimethylated pyridines 
(95%, entry 5).21 
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Table 23: Scope of methylated N-benzoyliminopyridinium ylides 
95%
93%
98%
99%
96%1
2
3
4
5
Entry Pyridine Product Yield
N
NBzN
1) 84 (1.2 equiv)
   THF:H2O (1:1)
   40 °C, 12 h
2) PhCOCl (1.5 equiv)
    10 % NaOH, rt, 4 h
R
R
87 88
H2NO NO2
O2N
84
N
N
NBz
N
N
NBz
N
N
NBz
N
N
NBz
N
N
NBz
56 89
95
192 193
194
195 196
197 198
 
The scope of the reaction was extended to electron withdrawing and electron donating 
groups (Table 24).21 In the case of electron donating groups, the corresponding ylides were 
obtained in excellent yields. However, substrates that had bulky groups at the 2-position 
showed a significant decrease in yield (54%, entry 3).  
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Table 24: Scope of substituted N-benzoyliminopyridinium ylides 
N
N
NBz
OMe
OMe
N
N
NBz
N
N
N
N
NBzOiPr
OiPr
N
N
N
N
NBz
N
N
NBz
N
N
NBz
93%
43%
54%
91%
94%1
2
3
4
5
Entry Pyridine Product Yield
N
NBzN
i) 84 (1.2 equiv)
   THF:H2O (1:1)
   40 °C, 12 h
ii) PhCOCl (1.5 equiv)
    10 % NaOH, rt, 4 h
R
R
87 88
H2NO NO2
O2N
84
6 94%
199 200
201 202
203 204
205 206
207 208
209 210
 
Electron withdrawing groups posed a challenge. None of the 2-substituted pyridines were 
aminated under various reaction conditions (Table 25). 
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Table 25: Scope of electron withdrawing 2-substituted N-benzoyliminopyridinium 
ylides 
0%
0%
0%1
2
3
Entry Product Yield
N
NBzN
i) 84 (1.2 equiv)
   THF:H2O (1:1)
   40 °C, 14 h
ii) PhCOCl (1.5 equiv)
    sat' d NaHCO3, rt, 1 h
211 212
H2NO NO2
O2N
84
R1
R1
Pyridine
NF
N
NBz
F
NCl
N
NBz
Cl
NNC
N
NBz
CN
213
214
215
216
217
218
 
No general trend was observed for 3-substituted pyridinium ylides. The best result was 
obtained with the 3-chloro derivative (Table 26, 94% yield, entry 1) whereas the 3-cyano 
derivative showed only trace product formation (Table 26, <5%, entry 2).21 The 
experiments were not conducted at higher temperatures due to safety issues concerning the 
aminating reagent. The onset temperature at which O-(2,4-dinitrophenyl)-hydroxylamine 
(84) is unstable occurs at 90 ˚C. 35 
 
 
 
 
 
                                                
35 Boyles, D.; Curran, T.; Parlett, R. Org. Process Res. Dev. 2002, 6, 230. 
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Table 26: Scope of 3-substituted N-benzoyliminopyridinium ylides 
67%
49%
<5%
94%1
2
3
4
Entry Product Yield
N
NBzN
i) 84 (1.2 equiv)
   THF:H2O (1:1)
   40 °C, 14 h
ii) PhCOCl (1.5 equiv)
    sat' d NaHCO3, rt, 1 h
219 220
H2NO NO2
O2N
84
Pyridine
N
N
NBz
N
N
NBz
N
N
NBz
R2
R2
Cl
NC
PhOC
Cl
CN
COPh
N
N
NBz
MeO2C
CO2Me
221 222
223 224
225 226
227 228
 
Similar results were obtained with pyridine derivatives substituted with electron 
withdrawing groups at the 4-position. In addition, a similar trend was observed as 
previously seen for 3-substituted substrates; the cyano-substituted pyridines afforded lower 
yields of aminated products (Table 27).21 
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Table 27: Scope of 4-substituted N-benzoyliminopyridinium ylides 
85%
75%
42%1
2
3
Entry Product Yield
N
NBzN
i) 84 (1.2 equiv)
   THF:H2O (1:1)
   40 °C, 14 h
ii) PhCOCl (1.5 equiv)
    sat' d NaHCO3, rt, 1 h
56 89
H2NO NO2
O2N
84
Pyridine
N
N
NBz
N
N
NBz
N
N
NBz
CN
COPh
CO2Me
CN
CO2Me
COPh
229 230
231 232
233 234
 
3.3 Scope of pyrazolo[1,5-a]pyridines  
3.3.1 Introduction 
With the optimal conditions and a large library of vinyl halides in hand, the scope of the   
C-H insertion/cyclization reaction was examined, first employing styryl iodide derivatives 
substituted with both electron donating and electron withdrawing substituents. We also 
tested non-sp2 alkenyl iodide derivatives for example cyclopropyl phenyl vinyl iodide 246 
(Scheme 21). Next, we explored styryl bromide derivatives and styryl chloride derivatives 
under the same reaction conditions. Finally, several substituted N-benzoyliminopyridinium 
ylides were synthesized and tested in our reaction affording 2-phenylpyrazolopyridine 
derivatives. 
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3.3.2 Synthesis of 2-substituted pyrazolo[1,5-a]pyridines from styryl iodide 
derivatives 
The developed method for the synthesis of 2-substituted pyrazolo[1,5-a]pyridines proved to 
be quite general. The products were formed in good yields with many substrates, including 
sterically hindered ortho substituted aryl vinyl iodide (Table 28, entry 3). 
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Table 28: Synthesis of 2-substituted pyrazolo[1,5-a]pyridines from styryl iodide 
derivatives  
158 236
N N
N N
1
2
3
I
I
I
80%
79%
70%
Entry Styryl iodide Product Yield
N
N
O
IR
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16 h
N N
R
N N
135
4
5
65%
87%
N N
OMe
N N
OBn
IMeO
I
BnO
N N
Br
N N
F
6
7
8
9
I
Br
I
F
70%
63%
86%
61%
N N
Cl
N N
CN
I
Cl
I
NC
176
126
132
128
130
167
163
161
103
237
238
239
240
241
242
243
244
245  
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Two electron-rich styryl iodide substrates were tested. Both were well tolerated, 
affording the desired product in good yield (Table 28). 
Electron-poor substrates were well tolerated although there was a slight drop in yield with 
the exception of the para fluorinated product that was obtained in 86% (Table 28, entry 8). 
Interestingly, the reactivity occurred specifically with the vinyl iodide; no arylated 
byproduct was detected by 1H NMR even when an aryl bromide moiety was present in the 
substrate (Table 28, entry 6). Therefore, the presence of a halogen on the phenyl substituent 
of the pyrazolopyridine derivatives permits for further functionalization via cross-coupling 
reactions.  
3.3.3 Synthesis of 2-substituted pyrazolo[1,5-a]pyridines from other alkenyl iodide 
derivatives 
We attempted our reaction with a cyclopropylvinyliodide derivative under our reaction 
conditions and obtained product 247 in 62% (Scheme 21). We believe the transformation 
was possible, because cyclopropane carbons have some sp2 character. As discussed below, 
sp3 substrates failed to afford the desired cyclized product. 
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Scheme 21: Synthesis of 2-substituted cyclopropanepyrazolo[1,5-a]pyridine from 
cyclopropyl phenyl vinyl iodide 
246 247135
N
N
O
I AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16 h
N N
62%
 
Phenyl or sp2 substituted alkenyl halides appear to be required for the formation of 
pyrazolo[1,5-a]pyridines under our reaction conditions. As mentioned above, sp3 
substituted alkenyl halides were not tolerated. As shown in Table 29, no cyclized products 
were obtained for all the sp3-functionalized substrates tested (entry 1,2,3). Although the 
ester group (entry 4) contains an sp2 carbon, the electron withdrawing ester might be the 
reason that 0% yield of 255 was obtained. Alternatively, its low reactivity may be due to its 
cis configuration. Clarification on the matter could be achieved by testing the 
corresponding Z-styryl iodide. 
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Table 29: Synthesis of various pyrazolo[1,5-a]pyridines 
236135
1
2
3
4
0%
0%
0%
0%
Entry Product Yield
N
N
O
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16 h
N N
R
I
N N
I
O
O
N N
O
O
I
4:1 E:Z mixture
N N
I CO2Et
N N
CO2Et
A
A
248
250
249
251
252 253
254
255  
3.3.4 Synthesis of substituted pyrazolo[1,5-a]pyridines from styryl halide derivatives 
We explored the less reactive styryl bromide derivatives under our reaction conditions and 
found that the desired cyclized product was formed in comparable yields to those obtained 
with their corresponding styryl iodides (Table 30).  
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Table 30: Synthesis of 2-substituted pyrazolo[1,5-a]pyridines from styryl bromides 
236135
N N
N N
N N
O
N N
Br
N N
F
1
2
3
4
5
Br
Br
Br
O
Br
Br
Br
F
80 (80)
76 (79)
63
60 (70)
79 (86)
Entry Styryl bromide Product Yield (%)a
N
N
O
BrR
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16h
N N
R
256
a yield in brackets are those obtained from styryl iodode analogue
187
190
191
188
189
237
238
242
244
257
 
Following up our previous work with alkenyl iodides (Table 31), we tested three alkenyl 
bromides. Again, the reaction failed to give the desired product (Table 31, entries 1 & 3). 
However, interestingly, we obtained the cyclized product with gem-phenylvinyl bromide in 
58% (Table 31, entry 2). This may be an indication that either sterics play an important role 
in the reaction or that conjugation is important. The mechanism of the reaction is addressed 
in the following chapter. 
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Table 31: Synthesis of various pyrazolo[1,5-a]pyridines from alkenyl bromides 
236135
1
2
3
0%
58%
0%
Entry Product Yield
N
N
O
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16 h
N N
R
A
A
Br
O
Br
Br
N N
O
N N
N N
245
246
247
248 249
237
 
Initial studies showed that styryl chlorides could also afford the desired product. These are 
far less reactive than their respective styryl iodides and styryl bromides and yet afford the 
desired pyrazolopyridine (Scheme 22, 16% yield). For lack of time, we did not pursue this 
avenue any further. 
Scheme 22: Synthesis of 2-phenylpyrazolo[1,5-a]pyridines from styryl chlorides 
237135 181
Cl
N
N
O
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16 h
N N
16%
 
3.3.5 Synthesis of 2-phenylpyrazolo[1,5-a]pyridine derivatives from substituted N-
benzoyliminopyridinium ylides 
Once we showed that the C-H insertion/cyclization proceeded in good yields for a variety 
of substituted styryl halides, we next explored substituted N-benzoyliminopyridinium 
ylides in our method for the synthesis of pyrazolo[1,5-a]pyridines. To that end, we repeated 
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the synthesis of a few substituted ylides previously reported by our group.21 The results 
were positive, forming the pyrazolo[1,5-a]pyridines in moderate to excellent yield for most 
examples (Table 32). 
3-Substituted N-benzoyliminopyridinium ylides formed regioisomers with poor 
regioselectivity (Table 32, entry 1 and 2). On the other hand, excellent regioselectivity was 
achieved with the isoquinoline ylide (Table 32, entry 3) forming a single product in 60% 
yield. 
Table 32: Synthesis of 2-phenylpropanepyrazolo[1,5-a]pyridine derivatives from 
substituted N-pyridinium ylide forming possible regioisomers 
251250 103
1
2
3
Entry Functionalized Ylide Product Yield
N
N
O
I
R
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16 h
N N
R
N
Cl N
Cl
N
Ph
N N
Ph N N
Ph
N NN N
major
0%only product
minor
major
N NBz
N
Cl NBz
N NBz
minor
77%
3:1
91%
2:1
60%
N
Ph
252 253
254 255
256
257
222
209
193
 
The remaining N-benzoyliminopyridinium ylide derivatives have been grouped together in 
Table 33. The quinoline example gave the best yield (90%, entry 1), and the electron 
withdrawing 4-cyano-N-benzoyliminopyridinium ylide afforded the corresponding 
pyrazolopyridine in 62% yield. No cyclized product was formed for 2-substituted substrates 
(entry 3 and 4).  
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Table 33: Synthesis of 2-phenylpyrazolo[1,5-a]pyridine derivatives from N-pyridinium 
ylide derivatives 
251250 103
1
2
3
4
Entry Functionalized Ylide Product Yield
N
N
O
I
R
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16 h
N N
R
N
NC
N
N N
N N
N N
N NBz
N NBz
N
NC
NBz
N NBz
62%
0%
0%
90%
230
208
95
252
356
354
355
353
 
3.3.6 Synthesis of 2,3-disubstituted pyrazolo[1,5-a]pyridine from an intramolecular 
cyclization 
Although no cyclized product was evident with 2-methyl-N-benzoyliminopyridinium ylide 
(Table 33, entry 4), complete consumption of the starting material formed an unknown 
compound. We isolated this unknown compound and discovered that an intramolecular 
cyclization occurred, affording product 258 (Scheme 23), instead of reacting with the styryl 
iodide. To prove that an intramolecular cyclization did occur we repeated the experiment 
without the addition of styryl iodide into the reaction, and again obtained product 258. The 
yield of the reaction was low (27%, Scheme 23). The benzoate at the 3 position comes from 
the silver benzoate. To verify what compound was obtained; a crystal structure of product 
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258 was obtained (Appendix 1). We did not pursue this avenue further due to lack of 
synthetic interest for the 2,3-disubstituted pyrazolo[1,5-a]pyridine product 258. 
Scheme 23: Intramolecular cyclization without styryl iodide 
258357
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16 h
N
N
O
N
N
O
O
27%
 
3.4 Conclusion 
Our methodology proved to be quite general. We were able to obtain 2-substituted 
pyrazolo[1,5-a]pyridines for both substituted styryl iodides and substituted N-
iminobenzoylpyridinium ylide. The reaction worked well with both electron rich and 
electron poor compounds. We were able to obtain some regioselectivities for 
unsymmetrically substituted N-iminobezoylpyridinium ylides. Interestingly, we obtained a 
single regioisomer for the isoquinoline ylide. We discovered that in the presence of a 
methyl substituent in the 2-position of the ylide, we do not obtain the corresponding 
pyrazolopyridine; instead, we obtained a product that resulted from an intramolecular 
cyclization onto the methyl group. The reaction also permitted the formation of cyclopropyl 
analogue 247 (Scheme 21). The methodology failed when reacted with tri-substituted and 
sp3 substituted vinyl iodides, the rational for which we will discuss in the next chapter. 
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Chapter 4: Mechanistic insight  
4.1 Introduction 
The mechanism of the cyclization/rearomatization reaction to form pyrazolopyridines 55 
(Chapter 3) has been studied in this chapter, with interest in knowing the individual roles 
played by the silver salt and palladium catalyst. We hypothesized three mechanisms for the 
reaction, and performed test reactions to evaluate certain mechanistic pathways. 
4.1.1 Catalytic cycle I  
In our first proposed mechanism (Scheme 27), the palladium catalyst undergoes oxidative 
addition into alkenyl iodide 146. The catalyst inserts into pyridinium ylide 135 to form 
intermediate 262. C-H insertion takes place and H-I is released. Silver benzoate can then 
trap the acid forming benzoic acid and silver iodide. Reductive elimination of 263 gives 
rise to 264. Silver can then activate the pi bond in 264 facilitating the cyclization step by 
withdrawing electron density from the system. Silver is eliminated as silver metal during 
the rearomatization stepthis was physically seen as a thin layer of silver metal covering 
the reaction vessel. Phenyl acetate de-protects the amine, forming final compound 55 and 
benzoic anhydride. Benzoic anhydride was protonated during aqueous work-up forming 
benzoic acid seen in the 1H NMR spectra (Scheme 24). 
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Scheme 24: Catalytic cycle I 
N
N
O
N
N
Ph
N
N
Ph
O
PdII
PdBr2
L
Pd0
I
Ph
PdII
Ph
IPh
O
Ph
O
N
N
O
Ph
Ph
AgI
N
N
Ph
AgI
O
Ph
N
N
Ph
O
Ph
AgI
2 x Ag0
AgI
aqueous
work-up
260
263
264265
266
267
146
135
55
N
NBz
PdII
H
262
I
HI
AgOBz
AgI + PhCO2H
Ph
 
4.1.2 Catalytic cycle II  
We also hypothesized a second mechanistic cycle (Scheme 25) based on the works of 
Sashida et al (Figure 8).12 The main difference of the mechanistic pathway in the second 
catalytic cycle is the silver oxidation of the double bond to a triple bond prior to the 
cyclization. Following reductive elimination, the alkene in 264 is oxidized by silver to form 
an alkyne in 268. Silver coordinates to the alkyne facilitating cyclization. Phenyl acetate 
de-protects the amine, and final compound 55 is obtained by protonolysis during the 
aqueous work-up. 
Figure 7: Intramolecular [3 + 2] cycloaddition 
N
R
H2NOMts
70-90%
N
R
NH2
MtsO
K2CO3
DMF, rt
15-95% N
R
NH
N
N
R
H
N
N
R
N
N
R
36 37 38275 276 277  
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Scheme 25: Catalytic cycle II 
N
N
Ph
N
N
Ph
O
PdII
O
Ph
O
N
N
O
Ph
Ph
N
N
Ph
O
Ph
PdBr2
L
Pd0
I
Ph
PdII
Ph
I
Ph
2 x AgI2 x Ag0
N
N
O
Ph Ph
N
N
Ph
O
Ph
AgI
AgI
AgI
AgI
AgI
N
N
Ph
aqueous
work-up
AgI
N
N
O
268
269
55
260
135
146
263
264
270
266
271 262
HI
AgOBz
AgI + PhCO2H
N
NBz
PdII
H
I
Ph
 
4.1.3 Catalytic cycle III  
Our third catalytic cycle differs from the first two cycles as it proposes the oxidation of the 
styryl iodide to an alkyne prior to the C-H insertion (Scheme 26). Palladium (II) bromide 
first inserts into pyridinium ylide 135. The C-H insertion releases hydrogen bromide that 
can be trapped by silver benzoate to form silver bromide and benzoic acid. Alkenyl iodide 
146 is oxidized to an alkyne via β-syn elimination. Alkyne 278 is coordinated by silver and 
adds to palladed ylide 281. Reductive elimination of 282 gives rise to 268. Following this 
point, catalytic cycle III undergoes the same steps as catalytic cycle II. 
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Scheme 26: Catalytic cycle III 
N
N
O
N
N
Ph
N
N
Ph
O
PdII
PdBr2
Pd0
I
Ph
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O
Ph
O
N
N
Ph
O
Ph
N
N
O
Ph
N
N
Ph
O
Ph Ph
AgI
Ph
AgI
AgI
AgI
N
N
Ph
AgI
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work-up
266
135
146
55
278
282
268
270
271
269
HBr
AgOBz
AgBr + PhCO2H
N
N
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O
PdII Br
Br
H
Ph
AgI
N
N
Ph
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PdII Ph
AgI
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4.2 Cyclization Studies 
4.2.1 Stepwise C-H insertion and cyclization study  
We investigated first whether pyrazolopyridine 55 could be obtained via the alkenylated 
pyridnium ylide to verify the final steps of both catalytic cycles I and II (Scheme 27).  
Scheme 27: Test reaction 1: Stepwise cyclization via an alkenylated pyridinium ylide 
N
NBz
N
NN
NBz
I
89 103 104 237
CuBr2 (10 mol%), 
K2CO3 (2 equiv)
PhCl (0.2 M), 
125 C, 16-24 h
 
We isolated alkenylated pyridinium ylide 10424 (Scheme 27) and resubmitted it to different 
reaction conditions to determine what was necessary for the cyclization step of the reaction.  
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Table 34: Reaction conditions for the cyclization of alkenylated pyridinium ylide 
237104
1
2
3
4
Entry P(4-MeOPh)3 Yield
Conditions
N N
44%
49%
0%
0%
N
NBz
AgBz PdBr2 Comment
dioxane, 125 °C, 16 h
none none none
none
none none
none
5 47%
only sm
0.15 equiv
0.15 equiv
0.15 equiv
0.05 equiv
0.05 equiv
3 equiv
3 equiv
3 equiv
only sm
 
As expected, heat alone was not responsible for the cyclization (Table 34, entry 1) and 
unreacted starting material was seen by 1H NMR spectroscopy. Without silver benzoate no 
product was obtained (entry 4) demonstrating that silver is necessary for the cyclization 
step of the reaction.  
Cyclization occurred without the use of palladium catalyst (Table 34, entry 2, and 3), but 
no C-H insertion can occur without the use of palladium catalyst (Table 16).  
4.2.2 Competing reaction pathways in order to determine the mechanism of the 
reaction  
We hypothesized a reaction to test two of the three mechanistic pathways. By reacting 
compound 247 (Scheme 28) with N-iminopyridinium ylide under our reaction conditions, 
two outcomes were possible. The test reaction would either favour a reaction pathway 
following catalytic cycle I giving rise to product 287 or catalytic cycle III giving rise to 
product 55. 
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Scheme 28: Test reaction 2: Alkene addition pathway forming a 3-
phenylpyrazolopyridine versus an alkyne addition pathway forming a 2-
phenylpyrazolopyridine 
N
NBz
PhN
NBz
N
N
Ph
O
Ph N
N
Ph
Br
Ph
89 247
285 286 287
N
NBz
N
NPh
O
Ph
Ph
N
N
Ph
288 289 55
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16 h
 
3-Phenyl pyrazolo[1,5-a]pyridine 287 was not obtained; instead compound 55 was 
obtained (Scheme 28). Pyrazolo[1,5-a]pyridine 55 was obtained in 58% yield suggesting 
that an alkyne C-H insertion pathway (catalytic cycle III) was taking place.  
In order to further verify that catalytic cycle III was the mechanistic pathway of the 
reaction, we tested tri-substituted alkenyl iodide 290 under our reaction conditions. We 
knew from previous work that alkenylated 291 was obtained in 48% yield under copper 
catalyzed reaction conditions (Scheme 29)24. Since 291 was previously synthesized, we 
believed that tri-substituted alkenyl iodide 291 would serve as a good control to test the 
reaction pathway for our reaction.  
Scheme 29: Alkenylation of N-iminopyridinium ylide with a tri-substituted vinyl halide 
N
NBz
I
Ph
Me
N
H
Ph
N
O
Ph
29129089
CuBr2 (10 mol%), 
K2CO3 (2 equiv)
PhCl (0.2 M), 
125 C, 16-24 h
(1.5 equiv)
(1 equiv)
 
Three different outcomes were possible and would give further insight on which pathway 
was taking place. Scheme 30 depicts the possible outcome of the reaction if it followed 
catalytic cycle I. By reacting tri-substituted alkenyl iodide 290, oxidation of 293 would not 
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be possible hence a pyrazolo pyridine would not be obtained. We would obtain 
compound 294 if the pathway of the reaction followed catalytic cycle I.  
Scheme 30: Test reaction with tri-substituted alkenyl iodide 290: Comparison with the 
catalytic cycle I model  
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16 h
I
Ph
146 N
Ph
N
O
Ph
264
N
N
Ph
Ph
O
Ag
Ag
N
N
Ph
OBz
[O]
N
N
Ph
Ph
O
N
NBz
I
Ph
290
89
N
H
Ph
N
O
Ph
292
N
N
PhPh
O
Ag
Ag
[O]
work-up
N
N
PhPh
O293 294
55
265
267
 
In the catalytic cycle II model, oxidation of alkene 295 to an alkyne is not possible hence 
we would obtain final product 296  (Scheme 31). 
Scheme 31: Test reaction with tri-substituted alkenyl iodide 290: Comparison with the 
catalytic cycle II model 
N
Ph
N
O
Ph
264
Ag
[O] N
N
O
Ph Ph
Ag
N
N
Ph
Ph
O
Ag
OBz
N
N
Ph
Agwork-upN
N
Ph
N
H
Ph
N
O
Ph
295
Ag
[O]
work-up N
H
Ph
N
O
Ph
I
Ph
146
N
NBz
I
Ph
290
89
296
55
268
270271
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16 h
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The third model following catalytic cycle III would result in no reaction (Scheme 32). 
Tri-substituted alkenyl iodide 290 cannot undergo the initial oxidation to form an alkyne 
prior to the C-H insertion and thus no reaction would take place. 
Scheme 32: Test reaction with tri-substituted alkenyl iodide 290: Comparison with the 
catalytic cycle III model 
[O] N
N
O
Ph Ph
Ag
N
N
Ph
Ph
O
Ag
OBz
N
N
Ph
Ag
work-up
N
N
Ph
Ph
[O]
work-up no reaction
I
Ph
146
N
NBz
I
Ph
290
89
55
279 268
270271
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16 h
Ag
 
The test reaction with tri-substituted alkenyl iodide 290 did not form either compound 294 
and 296; only starting material was isolated. This result once again supports catalytic cycle 
III as the mechanistic pathway of the reaction. 
In the above studies we learned two important factors necessary for the reaction to take 
place. First, we learned that an alkyne must be produced. Second, we found that this alkyne 
was formed prior to its insertion.  
These findings explain why none of the tri-substituted vinyl halides in our scope led to the 
formation of pyrazolopyridines (Figure 8). Tri-substituted vinyl halides cannot form alkyne 
intermediates due to their associated ring strain. No alkenylated products were obtained and 
only starting material was present at the end of each reaction.  
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Figure 8: Cyclized tri-substituted halo alkenes 
Br
O
I I
O
O
297 298 299  
4.3 Phenyl Acetylene  
4.3.1 Synthesis of 2-phenylpyrazolo[1,5-a]pyridines from phenylacetylene 
Due to the previous results (4.2 Catalytic cycle studies), phenyl acetylene was directly 
reacted with the N-iminopyridinium ylide under various reaction conditions in order to 
verify the validity of the formation of a triple bond prior to the C-H insertion into the N-
iminopyridinium ylide (Table 36).  
Table 35: Synthesis of 237 from phenylacetylene 
23789
1
2
3
4
Entry P(4-MeOPh)3 Yield
Conditions
N N
0%
0%
0%
0%
N
NBz
AgBz PdBr2 Comment
dioxane, 125 °C, 16 h
none none none
none
none none
none
5 56%
only sm
0.15 equiv
0.15 equiv
0.15 equiv
0.05 equiv
0.05 equiv
3 equiv
3 equiv
3 equiv
only sm
only sm
only sm
300
 
We tested the reaction under different reaction conditions as previously studied with the 
styryl iodide to determine the role of the palladium and silver in the reaction. As shown in 
Table 36, no product was obtained for all reaction conditions except for entry 5, where all 
silver, palladium catalyst, and ligand were added. This screening proved that both silver 
and palladium were necessary for the reaction to take place. We isolated 56% of compound 
237. Hence the formation of an alkyne prior to insertion is indeed possible. The yield 
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obtained was lower than for the reaction with styryl iodides. A readjustment of new 
optimal reaction conditions might have improved the yields.  
We know that cyclization can occur solely with silver benzoate therefore silver plays a role 
in the cyclization where it may facilitate cyclization by coordination to the alkyne. Further, 
palladium catalyst and silver benzoate both are required for the C-H insertion for vinyl 
halides and phenyl acetylene. Silver benzoate may be needed for the C-H insertion step as 
benzoate serves as a base. 
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Chapter 5: Conclusions and future work 
5.1 Summary and conclusions 
The one pot synthesis of 2-pyrazolo[1,5-a]pyridines from N-iminopyridinium ylide 
derivatives and styryl halides has herein been developed.  The reaction was discovered as a 
major product that resulted during the optimization attempt of an alkenylation of N-
iminopyridinium ylides when a silver base was used instead of the potassium carbonate 
base under palladium catalysis conditions. From this starting point, we optimized the 
reaction conditions for the synthesis of pyrazolopyridine 55 (Scheme 19). The final optimal 
reaction conditions were: N-benzoyliminopyridinium ylide (2 equiv), styryl iodide (1 
equiv), palladium bromide (5 mol %), tris-4-methoxyphenylphosphine (15 mol %), silver 
benzoate (3 equiv), at 125 °C for 16 hours where 2-pyrazolo[1,5-a]pyridine was obtained in 
80% yield (Scheme 19).  
With the optimal conditions in hand, we expanded the reaction to styryl iodides derivatives. 
The reaction proved to be quite general. Electron donating groups as well as electron 
withdrawing groups led to good yields; ranging from 65-87% yield for electron donating 
groups, and 61-86% for electron withdrawing groups.  
Styryl bromides produced pyrazolopyridines in good yields (63%-80%). Styryl chlorides, 
although much less reactive, afforded the pyrazolopyridine in 16% yield.  
Synthesis of 2-substituted cyclopropanepyrazolo[1,5-a]pyridine 247 from cyclopropyl 
phenyl vinyl iodide 246 and N-iminopyridinium ylide 135 was achieved in 62% yield 
(Scheme 21).  
Next, N-iminopyridinium ylide derivatives were screened and pyrazolo[1,5-a]pyridine 
derivatives were obtained in 60-91% yields. Regioisomers were obtained for 
asymmetrically substituted N-iminopyridinium ylides. Of the three substrates tested, two 
gave poor selectivities, however, the isoquinoline ylide gave rise to a single product in 60% 
yield.  
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An unexpected intramolecular cyclization, resulting in 27% yield, occurred when 2-
methyl-N-iminopyridinium ylide was tested under our reaction conditions. When the 
reaction was repeated in the absence of styryl halides, the same cyclization occurred 
(Scheme 23). 
5.2 Future Work 
Having shown that the formation of pyrazolopyridines can be accessed by the reaction of 
phenyl acetylene and pyridinium ylides, optimization studies and a reaction scope using 
phenyl acetylene derivatives as coupling partners would be an interesting avenue to 
explore.  
Herein, we have shown that an alkyne intermediate is formed in the process of forming 
pyrazolo[1,5-a]pyridines prior to the C-H insertion. A more in depth continuation of 
mechanistic studies would aid in truly understanding the reaction pathway. 
Since the pyrazolopyridines can be obtained by both the reaction of pyridinium ylides with 
phenyl acetylene and with styryl iodides, competing reactions between styryl iodide and 
phenyl acetylene and such derivatives could be explored to show that the reaction pathway 
favours one pathway over the other.  
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Chapter 6: Experimental 
6.1 General information 
All non-aqueous reactions were run under an inert atmosphere of argon with rigid 
exclusion of moisture from reagents and glassware using standard techniques for 
manipulating air-sensitive compounds.36 All glassware was stored in the oven and/or was 
flame-dried prior to use under an inert atmosphere of gas. Analytical thin-layer 
chromatography (TLC) was performed on precoated, glass-backed silica gel (Merck 60 
F254). Visualisation of the developped chromatogram was performed by natural 
fluorescence or fluorescence quenching at 254 nm UV light and/or aqueous cerium 
molybdate, or aqueous potassium permanganate. Flash column chromatography was 
performed using 230-400 mesh silica (EM Science or Silicycle) and the indicated solvent 
system according to standard technique. Melting points were obtained on a Büchi melting 
point apparatus and are uncorrected. Infrared spectra were taken on a Perkin Elmer 
Spectrum One FTIR and are reported in reciprocal centimeters (cm-1). Nuclear magnetic 
resonance spectra (1H, 13C, DEPT 135, COSY, HMQC) were recorded either on a Bruker 
AV 300, AMX 300, AV 400, ARX 400, or DMX 700 spectrometer. Chemical shifts for 1H 
NMR spectra are recorded in parts per million from tetramethylsilane with the solvent 
resonance as the internal standard (chloroform, δ 7.27 ppm). Data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet, mc = 
centered multiplet and br = broad), coupling constant in Hz, integration, and assignment. 
Chemical shifts for 13C NMR spectra are recorded in parts per million from 
tetramethylsilane using the central peak of deuterochloroform (δ 77.00 ppm) as the internal 
standard. All spectra were obtained with complete proton decoupling. When ambiguous, 
proton and carbon assignments were established using COSY, HMQC and DEPT 135 
experiments.  
 
                                                
36 Shriver, D.F.; Drezdzon, M.A. The manipulation of air-sensitive compounds; 2nd Edition; Wiley: New 
York, 1986. 
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6.2 Reagents 
Unless otherwise stated, commercial reagents were obtained from commercial sources 
(Sigma-Aldrich, Alfa Aesar or Strem) and used without purification. Anhydrous solvents 
were obtained either by filtration through drying columns (THF, diethyl ether, CH2Cl2, 
benzene, toluene, hexane) on a GlassContour system (Irvine, CA) or by distillation over 
calcium hydride (Et3N, pyridine, diisopropylamine). Molecular sieves were dried at 120 °C 
for 16 hours and stored in a dessicator. Air-sensitive compounds were stored and handled 
in a glovebox under an atmosphere of argon.  
6.3 Synthesis of the starting materials  
6.3.1 Synthesis of O-(2,4-dinitrophenyl)hydroxylamine  
N
O
O
O
NO2
NO2
83
NH2NH2•H2O (2 equiv)
DCM:MeOH (8:1)
0 °C, 8 h
93%
H2NO NO2
O2N
84  
O-(2,4-Dinitrophenyl)-hydroxylamine 84, (AF-02-084).  In a 2L Erlenmeyer flask was 
added 83 (17.1 g, 51.9 mmols, 1 equiv) and dichloromethane (500 mL). The reaction 
mixture was stirred at room temperature until the solid was fully dissolved, then cooled on 
ice/water bath and stirred for 30 min. keeping the temperature at 0 ˚C. To ensure a stable 
temperature, the water bath was insulated with cotton and foil. In a 125 mL Erlenmeyer 
flask was added 70 mL of cold methanol (chilled in fridge) and 7.55 mL hydrazine 
monohydrate (kept in fridge) and kept on an ice/water bath for 10 min. This solution was 
added quickly to the reaction mixture and stirred for 30 min. on an ice/water bath. The 
reaction mixture was left in ice/water bath for 8 h without stirring. The reaction flask was 
wrapped in foil and cotton. During this time a beaker was placed upside down on the 
Erlenmeyer flask. After 8 hrs, 1L of HCl (1.5 M) was added to the solution and stirred for 
20 min. on ice/water bath. The reaction was filtered, rinsing the filter cake with 
dichloromethane whilst keeping the filtration flask on an ice/water bath. The filtrate was 
extracted with CH2Cl2 (3x 500 mL). The solution was dried with sodium sulfate, filtered, 
and concentrated under reduced pressure (kept in dark). The rotary evaporator bath 
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temperature was kept cold and the product was collected and placed in the freezer 
immediately. It was crucial at this point to avoid re-dissolving the solid product obtained in 
more solution containing product and re-evaporating it as this would decompose the 
product (it will start turning redder and redder as this is done). The resulting light orange 
solid was dried under vacuum overnight and used without further purification (9.7 g, 48.7 
mmol, 94%). The product should be kept in the freezer and in the dark for storage. 
Spectroscopic data are in full agreement with the literature values.21 
 
6.3.2 Synthesis of N-pyridinium ylide derivatives 
N
NBz
N
i) 84 (1.2 equiv)
   THF:H2O (1:1)
   40 °C, 12 h
ii) PhCOCl (1.5 equiv)
    NaOH 10 %, rt, 4 h
56
89  
N-Benzoyliminopyridinium ylide 89, (AF-01-177). Spectroscopic data are in full 
agreement with the literature values.21 
 
N
NBz
N
i) 84 (1.2 equiv)
   THF:H2O (1:1)
   40 °C, 12 h
ii) PhCOCl (1.5 equiv)
    NaOH 10 %, rt, 4 h
207 208  
N-Benzoyliminoquinolinium ylide 208, (AF-02-108). Spectroscopic data are in full 
agreement with the literature values.21 
 
N
NBz
N
i) 84 (1.2 equiv)
   THF:H2O (1:1)
   40 °C, 12 h
ii) PhCOCl (1.5 equiv)
    NaOH 10 %, rt, 4 h
209 210  
N-Benzoyliminoisoquinolinium ylide 210, (AF-02-109). Spectroscopic data are in full 
agreement with the literature values.21 
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N
NBz
N
i) 84 (1.2 equiv)
   THF:H2O (1:1)
   40 °C, 12 h
ii) PhCOCl (1.5 equiv)
    NaOH 10 %, rt, 4 h
221 222
Cl Cl
 
3-Chloro-N-benzoyliminopyridinium ylide 222, (AF-02-113). Spectroscopic data are in 
full agreement with the literature values.21 
N
NBz
N
i) 84 (1.2 equiv)
   THF:H2O (1:1)
   40 °C, 12 h
ii) PhCOCl (1.5 equiv)
    NaOH 10 %, rt, 4 h
229 230
CN CN
 
4-Cyano-N-benzoyliminopyridinium ylide 230, (AF-02-116). Spectroscopic data are in 
full agreement with the literature values.21 
 
6.4 Synthesis of substituted pyrazolo[1,5-a]pyridines 
 
6.4.1 Synthesis of the 2-substituted phenylpyrazolo[1,5-a]pyridines from styryl 
iodide derivatives 
I
N N
1
2
3
4 5 6 7
8
103 237
N
N
O
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16h
89  
2-Phenylpyrazolo[1,5-a]pyridine 237, (AF-02-74). To a 3 mL conical microwave vial 
with spin vane pyridinium ylide (198 mg, 1.0 mmol, 2 equiv) was added. In glove box, 
para-tris-methoxyphenylphosphine (26.4 mg, 0.075 mmol, 0.15 equiv), palladium bromide 
(6.7 mg, 0.015 mmol, 0.05 equiv), and silver benzoate (343.5 mg, 1.5 mmol, 3 equiv) were 
added to the vial. The microwave vial was crimped shut. (E)-(2-iodovinyl)benzene34 (115 
mg, 0.5 mmol, 1 equiv) was dissolved in dioxane (2.5 mL, 0.2 molar) and was added to the 
microwave vial. The solution was heated in oil bath to 125 ºC with fast stirring. Within five 
minutes a colour change was observed. The mixture was stirred for 16 h. The solution was 
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cooled to room temperature. Dichloromethane was added and the precipitate was filtered 
on cotton plug and washed with dichloromethane. Saturated sodium bicarbonate was 
added, the two phases were separated, and the aqueous phase was extracted with 
dichloromethane. The combined organic phases were dried over sodium sulfate, filtered 
and concentrated under reduced pressure. 
The product was purified by column chromatography (hexane/dichloromethane, 5/95) to 
afford a light yellow powder in 78% yield (75.3 mg). Rf = 0.23 (hexanes/dichloromethane, 
1/9); m.p.: 110-113 ºC; 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 8.47 (d, 3J (H/H) = 6.9 Hz, 
1H; C-H), 7.97 (d, 3J (H/H) = 7.5 Hz, 2H;  C-H), 7.54-7.34 (m, 4H; C-H), 7.08 (t, 3J (H/H) 
= 7.8 Hz, 1H; C-H), 6.80 (s, 1H; C-H), 6.73 (t, 3J (H/H) = 6.8 Hz, 1H; C-H); 13C NMR (75 
MHz, CDCl3, 25 ºC): δ = 154.2, 142.5, 134.2, 129.6, 129.4, 129.2, 127.5, 124.2, 118.7, 
112.7, 94.4; FTIR (neat) 1630, 1467, 1327, 763, 688 cm–1; HRMS Calcd for C13H10N2 
(M+H)+: 195.0917. Found 195.0909. 
 
I
N
N
1
2
3
4
5 6 7
8
161 238  
2-(4-Methylphenyl)pyrazolo[1,5-a]pyridine 238, (AF-02-75).  The title compound was 
prepared by the procedure described above using (E)-1-(2-iodovinyl)-4-methylbenzene34 
(122 mg, 0.5 mmol, 1 equiv). The product was purified by column chromatography 
(hexanes/dichloromethane, 5/95) to give a light beige powder in 79% yield (82.5 mg). Rf = 
0.23 (hexanes/dichloromethane, 1/9); m.p.: 117-118 ºC; 1H NMR (300 MHz, CDCl3, 25 
ºC): δ = 8.49 (d, 3J (H/H) = 6.9 Hz, 1H; C-H), 7.90 (d, 3J (H/H) = 8.1 Hz,  2H;  C-H), 7.50 
(d, 3J (H/H) = 9.3 Hz, 1H; C-H), 7.30 (d, 3J (H/H) = 8.1 Hz, 2H; C-H), 7.08 (t, 3J (H/H) = 
8.0 Hz 1H; C-H), 6.77 (s, 1H; C-H); 6.72 (t, 3J (H/H) = 6.9 Hz, 1H; C-H), 2.41 (s, 3H; 
CH3); 13C NMR (75 MHz, CDCl3, 25 ºC): δ = 154.5, 142.6, 139.4, 131.4, 130.3, 129.2, 
127.8, 124.4, 118.5, 112.2, 94.7, 22.3; FTIR (neat) 827, 774, 744 cm–1; HRMS Calcd for 
C14H13N2 (M+H)+: 209.1073. Found 209.1064. 
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I
N
N
1
2
3
4
5 6 7
8
130 243
Cl
Cl 9
 
2-(2-Chlorophenyl)pyrazolo[1,5-a]pyridine 243, (AF-02-79). The title compound was 
prepared by the procedure described above using (E)-1-chloro-2-(2-iodovinyl)benzene34 
(132.2 mg, 0.5 mmol, 1 equiv). The product was purified by column chromatography 
(hexane/dichloromethane, 5/95) to give a yellow powder in 63% yield (72.4 mg). Rf = 0.5 
(hexanes/dichloromethane, 1/9); m.p.: 45-47 ºC; 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 
8.51 (d, 3J (H/H) = 7.2 Hz, 1H; C-H), 7.97 (d, 3J (H/H) = 6.9 Hz,  1H;  C-H), 7.58-7.49 (m, 
2H; C-H), 7.39-7.27 (m, 2H; C-H), 7.11 (t, 3J (H/H) = 7.8 Hz 1H; C-H), 7.04 (s, 1H; C-H); 
6.76 (t, 3J (H/H) = 6.9 Hz, 1H; C-H); 13C NMR (75 MHz, CDCl3, 25 ºC): δ = 151.8, 141.5, 
133.6, 133.1, 132.3, 131.2, 130.2, 129.3, 127.8, 124.2, 119.1, 112.9, 99.0; FTIR (neat) 
1518, 1462, 775, 740, 724 cm–1; HRMS Calcd for C13H10ClN2 (M+H)+: 229.0527. Found 
229.0527. 
 
I
N
N
1
2
3
4
5 6 7
128 244
F
F
 
2-(4-Fluorophenyl)pyrazolo[1,5-a]pyridine 244, (AF-02-76). The title compound was 
prepared by the procedure described above using (E)-1-fluoro-4-(2-iodovinyl)benzene34 
(124 mg, 0.5 mmol, 1 equiv). The product was purified by column chromatography 
(hexane/dichloromethane, 5/95) to give a beige powder in 86% yield (82.5 mg). Rf = 0.24 
(dichloromethane, 100%); m.p.: 145-147 ºC; 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 8.48 
(d, 3J (H/H) = 6.3 Hz, 1H; C-H), 7.95-7.90 (m,  2H;  C-H), 7.48 (d, 3J (H/H) = 8.4 Hz, 1H; 
C-H), 7.18-7.02 (m, 3H; C-H), 6.75-6.69 (m, 2H; C-H);   13C NMR (75 MHz, CDCl3, 25 
ºC): δ = 163.9 (d, J(C-F) = 246.9 Hz, 153.5, 142.5, 130.3, 129.3, 129.0, (d, J(C-F) = 7.8 
Hz, 124.3, 118.7, 116.5 (d, J(C-F) = 22.3 Hz, 112.6, 94.3; FTIR (neat) 1473, 1213, 836, 
772, 745, 728, 631 cm–1; HRMS Calcd for C13H10FN2 (M+H)+: 213.0823. Found 213.0814. 
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N
1
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4
5 6 7
8
167 240
9
O 10
O
 
2-(3-Methoxyohenyl)pyrazolo[1,5-a]pyridine 240, (AF-02-87). The title compound was 
prepared by the procedure described above using (E)-1-(2-iodovinyl)-3-methoxybenzene34 
(130 mg, 0.5 mmol, 1 equiv). The product was purified by column chromatography 
(dichloromethane, 100%) to give a yellow powder in 65% yield (73.4 mg). Rf = 0.23 
(dichloromethane, 100%); m.p.: 43-45 ºC; 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 8.48 (d, 
3J (H/H) = 6.9 Hz, 1H; C-H), 7.58-7.52 (m,  2H;  C-H), 7.49 (d, 3J (H/H) = 9.0 Hz, 1H; C-
H), 7.36 (t, 3J (H/H) = 8.3 Hz, 1H; C-H), 7.06 (t, 3J (H/H) = 6.9 Hz, 1H; C-H), 6.93 (d, 3J 
(H/H) = 8.1 Hz, 1H; C-H); 6.79 (s, 1H; C-H), 6.71 (t, 3J (H/H) = 6.9 Hz, 1H; C-H), 3.9 (s, 
3H; C-H); 13C NMR (75 MHz, CDCl3, 25 ºC): δ = 160.8, 154.2, 142.3, 135.6, 130.6, 129.4, 
123.7, 119.9, 118.7, 115.1, 112.6, 112.4, 94.8, 56.0; FTIR (neat) 1470, 1245, 1158, 1041, 
768 cm–1; HRMS Calcd for C14H12N2O (M+H)+: 225.1022. Found 225.1015. 
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N
1
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4
5 6 7
8
163 239
9
 
2-(2-Methylphenyl)pyrazolo[1,5-a]pyridine 239, (AF-02-71). The title compound was 
prepared by the procedure described above using (E)-1-(2-iodovinyl)-2-methylbenzene34 
(122 mg, 0.5 mmol, 1 equiv). The product was purified by column chromatography 
(dichloromethane, 100%) to give a light beige powder in 70% yield (73.3 mg). Rf = 0.27 
(dichloromethane, 100%); m.p.: 59-63 ºC; 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 8.52 (d, 
3J (H/H) = 6.9 Hz, 1H; C-H), 7.75-7.67 (m,  1H;  C-H), 7.55 (d, 3J (H/H) = 9.6 Hz, 1H; C-
H), 7.30 (s, 3H; C-H), 7.12 (t, 3J (H/H) = 6.8 Hz 1H; C-H), 6.67 (t, 3J (H/H) = 9.6 Hz, 1H; 
C-H), 6.65 (s, 1H; C-H), 2.56 (s, 3H; CH3); 13C NMR (75 MHz, CDCl3, 25 ºC): δ = 154.9, 
141.8, 137.4, 134.0, 131.8, 130.8, 129.3, 129.2, 126.8, 124.3, 118.7, 112.4, 97.8, 22.2; 
FTIR (neat) 1459, 1328, 1250, 759, 748, 724 cm–1; HRMS Calcd for C14H13N2 (M+H)+: 
209.1073. Found 209.1069. 
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1
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4
5 6 7
241
O
O 8
9 10
11
176  
2-[4-(Benzyloxy)phenyl]pyrazolo[1,5-a]pyridine 241, (AF-02-92). The title compound 
was prepared by the procedure described above using (E)-1-(2-iodovinyl)-4-
benzyloxybenzene34 (168 mg, 0.5 mmol, 1 equiv). The product was purified by column 
chromatography (dichloromethane, 100%) to give a light yellow powder in 87% yield (131 
mg). Rf = 0.24 (dichloromethane, 100%); m.p.: 164-165 ºC; 1H NMR (300 MHz, CDCl3, 
25 ºC): δ = 8.47 (d, 3J (H/H) = 6.9 Hz, 1H; C-H), 7.92 (d, 3J (H/H) = 9.0 Hz, 2H; C-H), 
7.50-7.31 (m,  6H;  C-H), 7.10-7.04 (m, 3H; C-H), 6.73-6.67 (m, 2H; C-H), 5.13 (s, 2H; 
CH2), 13C NMR (75 MHz, CDCl3, 25 ºC): δ = 160.1, 154.4, 142.5, 137.9, 129.5, 129.3, 
128.8, 128.6, 128.4, 127.1, 124.3, 118.6, 115.9, 112.2, 93.9, 71.0; FTIR (neat) 1451, 1250, 
1043, 836, 777, 725, 694 cm–1; HRMS Calcd for C20H17N2O (M+H)+: 301.1335. Found 
301.1331. 
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N
N
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8
132 242
9Br
Br
 
2-(2-Bromophenyl)pyrazolo[1,5-a]pyridine  242, (AF-02-91). The title compound was 
prepared by the procedure described above using (E)-1-bromo-2-(2-iodovinyl)benzene34 
(154.5 mg, 0.5 mmol, 1 equiv). The product was purified by column chromatography 
(dichloromethane, 100%) to give a yellow-brown powder in 70% yield (96 mg). Rf = 0.39 
(dichlomethane/hexane, 9/1); m.p.: 45-46 ºC; 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 8.51 
(d, 3J (H/H) = 6.9 Hz, 1H; C-H), 7.83 (d, 3J (H/H) = 7.2 Hz, 1H;  C-H), 7.73 (d, 3J (H/H) = 
8.1 Hz, 1H; C-H), 7.58 (d, 3J (H/H) = 8.4 Hz, 1H; C-H), 7.43 (t, 3J (H/H) = 7.8 Hz,  1H; C-
H), 7.27 (t, 3J (H/H) = 8.1 Hz,  1H; C-H), 7.14 (t, 3J (H/H) = 8.1 Hz,  1H; C-H), 6.99 (s, 1H; 
C-H), 6.78 (t, 3J (H/H) = 6.6 Hz,  1H; C-H); 13C NMR (75 MHz, CDCl3, 25 ºC): δ = 153.5, 
141.5, 135.4, 134.5, 132.7, 130.5, 129.3, 128.3, 124.2, 123.3, 119.0, 112.8, 98.8; FTIR 
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(neat) 1519, 1458, 1330, 1024, 755, 737, 726 cm–1; HRMS Calcd for C13H10BrN2 
(M+H)+: 273.0022. Found 273.0029. 
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4-Pyrazolo[1,5-a]pyridin-2-ylbenzonitrile 245, (AF-02-77). The title compound was 
prepared by the procedure described above using (E)-4-(2-iodovinyl)benzonitrile34 (127.5 
mg, 0.5 mmol, 1 equiv). The product was purified by column chromatography 
(dichloromethane, 100%) to give a white powder in 61% yield (67 mg). Rf = 0.22 
(hexanes/dichloromethane, 1/9); m.p.: 214-216 ºC; 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 
8.46 (d, 3J (H/H) = 6.9 Hz, 1H; C-H), 8.05 (d, 3J (H/H) = 8.4 Hz, 2H; C-H), 7.72 (d, 3J 
(H/H) = 8.4 Hz, 2H; C-H), 7.54 (d, 3J (H/H) = 9.3 Hz, 1H; C-H), 7.13 (t, 3J (H/H) = 7.9 Hz, 
1H;  C-H), 6.84 (s, 1H; C-H), 6.80 (t, 3J (H/H) = 6.6 Hz,  1H; C-H);  13C NMR (75 MHz, 
CDCl3, 25 ºC): δ = 152.3, 142.7, 138.7, 133.2, 129.6, 127.7, 124.6, 119.9, 119.1, 113.4, 
112.5, 95.3; FTIR (neat) 1505, 1427, 842, 778, 753, 733 cm–1; HRMS Calcd for C14H10N3 
(M+H)+: 220.0869. Found 220.0863. 
6.4.2 Synthesis of the 2-substituted pyrazolo[1,5-a]pyridines from alkenyl iodide 
derivatives 
10
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2-(2-Phenylcyclopropyl)pyrazolo[1,5-a]pyridine 247, (AF-02-83). The title compound 
was prepared by the procedure described above using (E)-2-phenylcyclopropyl-2-
iodovinyl34 (135 mg, 0.5 mmol, 1 equiv). The product was purified by column 
chromatography (hexane/dichloromethane, 5/95) to give a light brown powder in 62% yield 
(73 mg). Rf = 0.26 (dichlomethane/hexane, 95/5); m.p.: 53-55 ºC; 1H NMR (300 MHz, 
CDCl3, 25 ºC): δ = 8.371 (d, 3J (H/H) = 7.5 Hz, 1H; C-H), 7.35 (d, 3J (H/H) = 8.4 Hz, 1H;  
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C-H), 7.34-7.29 (m, 2H; C-H), 7.22-7.17 (m, 3H; C-H), 7.04 (t, 3J (H/H) = 7.8 Hz,  1H; 
C-H), 6.65 (t, 3J (H/H) = 6.9 Hz,  1H; C-H), 6.28 (s,  1H; C-H), 2.49-2.36 (m, 2H; CH2), 
1.69-1.62 (m, 1H; C-H), 1.55-1.48 (m, 1H; C-H);  13C NMR (75 MHz, CDCl3, 25 ºC): δ = 
157.6, 143.0, 142.0, 129.2,  129.0, 126.7, 126.6, 124.1, 118.1, 111.7, 94.4, 28.4, 22.6, 19.3; 
FTIR (neat) 1520, 1493, 764, 745, 695 cm–1; HRMS Calcd for C16H15N2 (M+H)+: 
235.1230. Found 235.1237. 
6.4.3 Synthesis of the 2-substituted pyrazolo[1,5-a]pyridines from styryl bromide 
derivatives 
N
N
O
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16h
Br
N N
1
2
3
4 5 6 7
187 237
8
89  
2-Phenylpyrazolo[1,5-a]pyridine 237, (AF-02-98). To a 3 mL conical microwave vial 
with spin vane pyridinium ylide (99.11 mg, 0.5 mmol, 2 equiv) was added. In glove box, 
para-tris-methoxyphenylphosphine (13.21 mg, 0.0375 mmol, 0.15 equiv), palladium 
bromide (3.3 mg, 0.0125 mmol, 0.05 equiv), and silver benzoate (171.7 mg, 0.75 mmol, 3 
equiv) were added to the vial. The microwave vial was crimped shut. (E)-(2-
bromovinyl)benzene34 (45.75 mg, 0.25 mmol, 1 equiv) was dissolved in dioxane (1.25 mL, 
0.2 molar) and was added to the microwave vial. The solution was heated to 125 ºC in an 
oil bath with fast stirring. Within five minutes a colour change was observed. The mixture 
was stirred for 16 h. The solution was cooled to room temperature. Dichloromethane was 
added and the precipitate was filtered on cotton plug and washed with dichloromethane. 
Saturated sodium bicarbonate was added, the two phases were separated, and the aqueous 
phase was extracted with dichloromethane. The combined organic phases were dried over 
sodium sulfate, filtered and concentrated under reduced pressure. 
The product was purified by column chromatography (hexane/dichloromethane, 5/95) to 
give a light yellow powder in 80% yield (39 mg). Rf = 0.23 (hexanes/dichloromethane, 
1/9); m.p.: 110-113 ºC. 
Spectroscopic data are in full agreement with iodo-analogue 103 above. 
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2-(4-Methylphenyl)pyrazolo[1,5-a]pyridine 238, (AF-02-99). The title compound was 
prepared by the procedure described above using (E)-1-(2-bromovinyl)-4-methylbenzene34 
(49.3 mg, 0.25 mmol, 1 equiv). The product was purified by column chromatography 
(hexanes/dichloromethane, 5/95) to give a light beige powder in 76% yield (39.3 mg). Rf = 
0.23 (hexanes/dichloromethane, 1/9); m.p.: 117-118 ºC. 
Spectroscopic data are in full agreement with iodo-analogue 161 above.  
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2-(4-Fluorophenyl)pyrazolo[1,5-a]pyridine 244, (AF-02-101). The title compound was 
prepared by the procedure described above using (E)-1-fluoro-4-(2-bromovinyl)benzene34 
(50.3 mg, 0.25 mmol, 1 equiv). The product was purified by column chromatography 
(hexane/dichloromethane, 5/95) to give a beige powder in 79% yield (42 mg). Rf = 0.25 
(dichloromethane, 100%); m.p.: 145-147 ºC. 
Spectroscopic data are in full agreement with iodo-analogue 128 above. 
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2-(2-Bromophenyl)pyrazolo[1,5-a]pyridine 242, (AF-02-102). The title compound was 
prepared by the procedure described above using (E)-1-bromo-2-(2-bromovinyl)benzene34 
(65.5 mg, 0.25 mmol, 1 equiv). The product was purified by column chromatography 
(hexanes/dichloromethane, 1/9) to give a yellow-brown powder in 60% yield (41 mg). Rf = 
0.45 (dichlomethane, 100%); m.p.: 45-46 ºC. 
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Spectroscopic data are in full agreement with iodo-analogue 132 above. 
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2-(4-Methoxyphenyl)pyrazolo[1,5-a]pyridine 257, (AF-02-100). The title compound was 
prepared by the procedure described above using (E)-1-(2-bromovinyl)-4-
methoxybenzene34 (53.3 mg, 0.25 mmol, 1 equiv). The product was purified by column 
chromatography (hexane/dichloromethane, 5/95) to give a beige powder in 63% yield (35.2 
mg). Rf = 0.2 (hexanes/dichloromethane, 1/9); m.p.: 123-125 ºC; 1H NMR (300 MHz, 
CDCl3, 25 ºC): δ = 8.46 (d, 3J (H/H) = 7.5 Hz, 1H; C-H), 7.91 (d, 3J (H/H) = 8.4 Hz,  2H;  
C-H), 7.48 (d, 3J (H/H) = 9.6 Hz,  1H; C-H), 7.07 (t, 3J (H/H) = 8.7 Hz,   1H; C-H), 6.99 (d, 
3J (H/H) = 9.6 Hz 2H; C-H), 6.72-6.68 (m, 2H; C-H); 3.86 (s, 3H; CH3); 13C NMR (75 
MHz, CDCl3, 25 ºC): δ = 160.8, 154.4, 142.5, 129.3, 128.6, 126.8, 123.9, 118.7, 114.9, 
112.2, 93.9, 56.2; FTIR (neat) 1462, 1242, 1028, 843, 770, 739 cm–1; HRMS Calcd for 
C14H13N2O (M+H)+: 225.1022. Found 225.1021. 
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6.5 Synthesis of 2-phenylpyrazolo[1,5-a]pyridine derivatives 
6.5.1 Synthesis of 2-phenylpyrazolo[1,5-a]pyridine derivatives 
I
AgOBz (3 equiv)
P(4-MeOPh)3 (0.15 equiv)
PdBr2 (0.05 equiv)
dioxane,125 °C, 16h
N N
1
2
3
4 5 6
230 354
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2-Phenylpyrazolo[1,5-a]pyridine-5-carbonitrile 354, (AF-02-141). To a 3 mL conical 
microwave vial with spin vane 4-cyano-N-benzoyliminopyridinium ylide (219 mg, 1.0 
mmol, 2 equiv) was added. In glove box, para-tris-methoxyphenylphosphine (26.4 mg, 
0.075 mmol, 0.15 equiv), palladium bromide (6.7 mg, 0.025 mmol, 0.05 equiv), and silver 
benzoate (343.5 mg, 1.5 mmol, 3 equiv) were added to the vial. The microwave vial was 
crimped shut. (E)-(2-iodovinyl)benzene34 (115 mg, 0.5 mmol, 1 equiv) was dissolved in 
dioxane (2.5 mL, 0.2 molar) and was added to the microwave vial. The solution was heated 
to 125 ºC in an oil bath with fast stirring. Within five minutes a colour change was 
observed. The mixture was stirred for 16 h. The solution was cooled to room temperature. 
Dichloromethane was added and the precipitate was filtered on cotton plug and washed 
with dichloromethane. Saturated sodium bicarbonate was added, the two phases were 
separated, and the aqueous phase was extracted with dichloromethane. The combined 
organic phases were dried over sodium sulfate, filtered and concentrated under reduced 
pressure. 
The product was purified by column chromatography (hexane/dichloromethane, 5/95) to 
give a yellow powder in 62% yield (67.4 mg). Rf = 0.2 (hexanes/dichloromethane, 1/9); 
m.p.: 186-189 ºC; 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 8.51 (d, 3J (H/H) = 7.2 Hz, 1H; 
C-H), 7.96-7.92 (m, 3H;  C-H), 7.50-7.38 (m, 3H; C-H), 7.6.99 (s, 1H; C-H), 6.83 (d, 3J 
(H/H) = 7.4 Hz,  1H; C-H);  13C NMR (75 MHz, CDCl3, 25 ºC): δ = 156.1, 140.8, 132.7, 
130.2, 130.1, 129.8, 127.5, 125.3, 118.4, 112.5, 107.7, 97.7; FTIR (neat) 1431, 898, 791, 
753, 718, 680, 623 cm–1; HRMS Calcd for C14H10N3 (M+H)+: 220.0869. Found 220.0871. 
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2-Phenylpyrazolo[1,5-a]quinoline 356, (AF-02-120). The title compound was prepared by 
the procedure described above using N-benzoyliminoquinolinium ylide (248 mg, 1.0 mmol, 
2 equiv). The product was purified by column chromatography (hexane/dichloromethane, 
10/90) to give a yellow powder in 90% yield (110.2 mg). Rf = 0.81 (dichlomethane, 100%); 
m.p.: 92-95 ºC; 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 8.70 (d, 3J (H/H) = 8.7 Hz, 1H; C-
H), 8.07 (d, 3J (H/H) = 8.1 Hz, 2H; C-H), 7.75 (m, 2H; C-H), 7.52-7.37 (m, 6H; C-H), 6.90 
(s, 1H;  C-H);  13C NMR (75 MHz, CDCl3, 25 ºC): δ = 153.7, 140.4, 135.8, 134.4, 130.2, 
129.6, 129.2 (2), 127.2, 125.5, 125.4, 124.0, 117.5, 116.4, 97.6; FTIR (neat) 1454, 812, 
753, 743, 690, 679 cm–1; HRMS Calcd for C17H13N2 (M+H)+: 245.1073. Found 245.1073. 
 
6.5.2 Synthesis of 2-phenylpyrazolo[1,5-a]pyridine regioisomers 
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6-Methyl-2-phenylpyrazolo[1,5-a]pyridine 252, (AF-02-94). The title compound was 
prepared by the procedure described above using 3-methyl-N-benzoyliminopyridinium 
ylide (212 mg, 1.0 mmol, 2 equiv). The product was purified by column chromatography 
(hexane/dichloromethane, 10/90) to give a beige powder in 77% combined yield (60 mg of 
252, 20 mg of 253). Rf = 0.4 (hexanes/dichlomethane, 1/9); m.p.: 121-129 ºC; 1H NMR 
(300 MHz, CDCl3, 25 ºC): δ = 8.29 (s, 1H; C-H), 7.98 (d, 3J (H/H) = 7.8 Hz, 2H; C-H), 
7.52-7.34 (m, 4H; C-H), 6.94 (d, 3J (H/H) = 8.4 Hz,  1H; C-H), 6.75 (s, 1H;  C-H), 2.31 (s, 
3H; C-H);  13C NMR (75 MHz, CDCl3, 25 ºC): δ = 153.7, 143.7, 141.2, 134.4, 129.6, 
129.0, 127.4, 123.2, 122.4, 118.0, 112.7, 94.1, 93.5, 18.8; FTIR (neat) 1438, 809, 761, 723, 
691 cm–1; HRMS Calcd for C14H13N2 (M+H)+: 209.1073. Found 209.1069. 
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4-Chloro-2-phenylpyrazolo[1,5-a]pyridine 254, (AF-02-121). The title compound was 
prepared by the procedure described above using 3-chloro-N-benzoyliminopyridinium 
ylide (232.7 mg, 1.0 mmol, 2 equiv). The product was purified by column chromatography 
(hexane/dichloromethane, 10/90) to give a beige powder in 91% combined yield (2:1 ratio) 
(69 mg 254, 35 mg 255). Rf = 0. 7 (dichlomethane, 100%); m.p.: 104-106 ºC; 1H NMR 
(300 MHz, CDCl3, 25 ºC): δ = 8.40 (d, 3J (H/H) = 7.2 Hz, 1H; C-H), 8.99 (d, 3J (H/H) = 7.5 
Hz, 2H; C-H),  7.51-7.38 (m, 3H; C-H), 7.14 (d, 3J (H/H) = 7.5 Hz,  1H; C-H), 6.96 (s, 1H;  
C-H), 6.67 (t, 3J (H/H) = 7.2 Hz, 1H; C-H);  13C NMR (75 MHz, CDCl3, 25 ºC): δ = 154.7, 
141.8, 133.4, 129.9, 129.6, 128.0, 127.4, 124.6, 123.4, 112.0, 94.8; FTIR (neat) 954, 747, 
712, 683, 644 cm–1; HRMS Calcd for C13H10ClN2 (M+H)+: 229.0527. Found 229.0521. 
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2-Phenylpyrazolo[1,5-a]isoquinoline 256, (AF-02-140). The title compound was prepared 
by the procedure described above using N-benzoyliminoisoquinolinium ylide (244 mg, 1.0 
mmol, 2 equiv). The product was purified by column chromatography 
(hexane/dichloromethane, 10/90) to give a beige powder in 60% yield (73.7 mg). Rf = 0.75 
(dichloromethane, 100%); m.p.: 115-117 ºC; 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 8.27 
(d, 3J (H/H) = 6.9 Hz, 1H; C-H), 8.12 (d, 3J (H/H) = 7.8 Hz, 1H;  C-H), 8.03 (d, 3J (H/H) = 
6.3 Hz, 2H; C-H), 7.65 (d, 3J (H/H) = 8.1 Hz, 1H; C-H), 7.62-7.47 (m, 4H; C-H), 7.44-7.37 
(m, 1H; C-H), 7.29 (s,  1H; C-H), 6.98 (d, 3J (H/H) = 7.8 Hz, 1H; C-H);  13C NMR (75 
MHz, CDCl3, 25 ºC): δ = 153.9, 140.7, 134.0, 129.7 (3), 129.2, 128.8, 128.5, 128.1, 127.2 
(3), 125.3, 124.6, 113.0, 95.4; FTIR (neat) 1537, 1460, 1360, 792, 756, 738, 695 cm–1; 
HRMS Calcd for C17H13N2 (M+H)+: 245.1073. Found 245.1067. 
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6.6 Synthesis of the intramolecular 2,3-substituted pyrazolo[1,5-
a]pyridine 
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2-Phenylpyrazolo[1,5-a]pyridin-3-yl benzoate 258, (AF-02-137). To a 3 mL conical 
microwave vial with spin vane pyridinium ylide (106 mg, 0.5 mmol, 1 equiv) was added. In 
glove box, para-tris-methoxyphenylphosphine (26.4 mg, 0.075 mmol, 0.15 equiv), 
palladium bromide (6.7 mg, 0.025 mmol, 0.05 equiv), and silver benzoate (343.5 mg, 1.5 
mmol, 3 equiv) were added to the vial. The microwave vial was crimped shut. Dioxane (0.2 
molar) was added to the microwave vial. The solution was heated to 125 ºC in an oil bath 
with fast stirring. The mixture was stirred for 16 h. The solution was cooled to room 
temperature. Dichloromethane was added and the precipitate was filtered on cotton plug 
and washed with dichloromethane. Saturated sodium bicarbonate was added, the two 
phases were separated, and the aqueous phase was extracted with dichloromethane. The 
combined organic phases were dried over sodium sulfate, filtered and concentrated under 
reduced pressure. The product was purified by column chromatography 
(hexane/dichloromethane, 10/90) to give a beige powder in 26% yield (41 mg). Rf = 0.25 
(hexanes/dichlomethane, 1/9); m.p.: 125-126 ºC; 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 
8.41 (d, 3J (H/H) = 7.2 Hz, 1H; C-H), 8.31 (d, 3J (H/H) = 7.8 Hz, 2H; C-H), 7.99 (d, 3J 
(H/H) = 8.1 Hz, 2H; C-H), 7.69 (t, 3J (H/H) = 7.5 Hz,  1H; C-H), 7.56 (t, 3J (H/H) = 7.8 Hz,  
2H; C-H), 7.33-7.46 (m, 3H; C-H), 7.10 (t, 3J (H/H) = 7.8 Hz,  1H; C-H), 6.76 (t, 3J (H/H) = 
6.9 Hz,  1H; C-H),;  13C NMR (75 MHz, CDCl3, 25 ºC): δ = 165.4, 144.4, 134.9, 134.2, 
132.3, 131.4, 129.7, 129.6, 129.5, 129.4, 129.3, 128.3, 124.0, 122.9, 117.3, 113.0; FTIR 
(neat) 1740, 1263, 1245, 1089, 740, 701, 679 cm–1; HRMS Calcd for C20H14N2O2 (M+H)+: 
315.1128. Found 315.1134. 
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Appendix I 
Crystal structure of 2-phenylpyrazolo[1,5-a]pyridin-3-yl benzoate  258 
 
Equipe Charette  
Département de chimie, Université de Montréal,  
C.P. 6128, Succ. Centre-Ville, Montréal, Québec, H3C 3J7 (Canada)  
Structure solved and refined in the laboratory of X-ray diffraction Université de Montréal 
by Francine Bélanger.  
 
Table 1.  Crystal data and structure refinement for C20H14N2O2.  
   
   
   Identification code  cha195  
   
      Empirical formula  C20H14N2O2  
   
      Formula weight   314.33  
   
      Temperature   150K  
   
      Wavelength   1.54178 Å  
   
      Crystal system   Monoclinic  
   
      Space group   P21/n  
   
      Unit cell dimensions  a = 3.9864(3) Å     a = 90°  
           b = 21.6026(15) Å     b = 93.004(5)°  
           c = 17.7499(14) Å     g = 90°  
   
      Volume    1526.5(2)Å3  
   
      Z     4  
   
      Density (calculated)  1.368  g/cm3  
   
   Absorption coefficient  0.724 mm-1  
   
      F(000)    656  
   
      Crystal size   0.15 x 0.05 x 0.03 mm  
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      Theta range for data collection 3.22 to 67.39°  
   
      Index ranges   –3 ≤ h ≤ 4, –25 ≤ k ≤ 25, –21 ≤ l ≤ 21 
   
      Reflections collected  23109  
   
      Independent reflections  2728 [Rint = 0.064]  
   
      Absorption correction  Semi-empirical from equivalents  
   
      Max. and min. transmission 0.9785 and 0.6860  
   
      Refinement method  Full-matrix least-squares on F2  
   
      Data / restraints / parameters 2728 / 0 / 217  
   
      Goodness-of-fit on F2  1.098  
   
      Final R indices [I>2sigma(I)]  R1 = 0.0586, wR2 = 0.1396  
   
      R indices (all data)   R1 = 0.0724, wR2 = 0.1519  
   
      Largest diff. peak and hole  0.275 and -0.412 e/Å3  
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Table 2.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(Å 2 x 103) for C20H14N2O2. 
 
Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
 
  x y z Ueq 
N(1) 2175(4) 5980(1) 4899(1) 38(1) 
N(2) 4015(4) 5861(1) 5543(1) 40(1) 
C(3) 4008(5) 6400(1) 5941(1) 38(1) 
C(4) 2139(5) 6846(1) 5528(1) 38(1) 
C(5) 950(5) 6583(1) 4859(1) 38(1) 
C(6) -1016(5) 6762(1) 4215(1) 42(1) 
C(7) -1694(5) 6342(1) 3656(1) 46(1) 
C(8) -418(5) 5727(1) 3728(1) 46(1) 
C(9) 1479(5) 5555(1) 4343(1) 43(1) 
O(10) 1352(4) 7437(1) 5786(1) 41(1) 
C(11) 2491(5) 7934(1) 5400(1) 39(1) 
O(11) 4019(4) 7892(1) 4843(1) 53(1) 
C(12) 1611(5) 8522(1) 5778(1) 39(1) 
C(13) 20(5) 8535(1) 6453(1) 44(1) 
C(14) -670(6) 9098(1) 6791(1) 51(1) 
C(15) 269(6) 9645(1) 6447(2) 56(1) 
C(16) 1858(6) 9631(1) 5781(2) 54(1) 
C(17) 2531(5) 9075(1) 5435(1) 47(1) 
C(18) 5746(5) 6435(1) 6685(1) 39(1) 
C(19) 7465(6) 5918(1) 6980(1) 46(1) 
C(20) 9075(6) 5934(1) 7682(1) 51(1) 
C(21) 9036(6) 6463(1) 8122(1) 51(1) 
C(22) 7331(6) 6980(1) 7837(1) 52(1) 
C(23) 5737(6) 6969(1) 7131(1) 45(1) 
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Table 3. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) 
for C20H14N2O2. 
 
  
  x y z Ueq 
H(6) -1864 7172 4170 50 
H(7) -3017 6459 3219 55 
H(8) -913 5436 3337 55 
H(9) 2320 5144 4388 51 
H(13) -600 8159 6685 53 
H(14) -1772 9109 7253 62 
H(15) -195 10031 6675 67 
H(16) 2505 10008 5555 64 
H(17) 3606 9068 4970 57 
H(19) 7520 5549 6689 55 
H(20) 10234 5577 7868 62 
H(21) 10150 6472 8609 61 
H(22) 7267 7346 8132 62 
H(23) 4612 7329 6943 54 
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Table 4. Anisotropic parameters (Å2 x 103) for C20H14N2O2. 
The anisotropic displacement factor exponent takes the form:  
  -2 π2 [ h2 a*2 U11 + ... + 2 h k a* b* U12    
  U11 U22 U33 U23 U13 U12 
N(1) 52(1) 17(1) 47(1) -1(1) 8(1) 0(1) 
N(2) 55(1) 19(1) 46(1) 0(1) 7(1) 0(1) 
C(3) 51(1) 19(1) 47(1) 0(1) 13(1) -1(1) 
C(4) 53(1) 15(1) 47(1) -2(1) 11(1) 1(1) 
C(5) 50(1) 16(1) 49(1) 0(1) 12(1) 1(1) 
C(6) 54(1) 23(1) 49(1) 1(1) 8(1) 2(1) 
C(7) 54(1) 35(1) 50(1) -1(1) 5(1) 3(1) 
C(8) 57(1) 28(1) 54(1) -8(1) 8(1) -4(1) 
C(9) 56(1) 20(1) 53(1) -6(1) 10(1) -1(1) 
O(10) 59(1) 15(1) 49(1) -1(1) 12(1) 3(1) 
C(11) 53(1) 20(1) 43(1) 2(1) 4(1) 1(1) 
O(11) 81(1) 24(1) 55(1) 0(1) 23(1) 0(1) 
C(12) 49(1) 21(1) 45(1) -1(1) -4(1) 3(1) 
C(13) 54(1) 29(1) 49(1) -4(1) -1(1) 6(1) 
C(14) 55(1) 40(1) 58(1) -15(1) -3(1) 11(1) 
C(15) 56(1) 28(1) 81(2) -18(1) -13(1) 9(1) 
C(16) 59(1) 20(1) 81(2) -2(1) -6(1) 0(1) 
C(17) 56(1) 23(1) 62(1) 3(1) 0(1) 1(1) 
C(18) 50(1) 22(1) 46(1) 3(1) 11(1) -1(1) 
C(19) 58(1) 27(1) 52(1) 1(1) 8(1) 2(1) 
C(20) 60(1) 38(1) 57(1) 10(1) 6(1) 4(1) 
C(21) 55(1) 49(1) 48(1) 4(1) 4(1) -4(1) 
C(22) 65(1) 39(1) 53(1) -7(1) 9(1) -2(1) 
C(23) 58(1) 27(1) 51(1) -1(1) 8(1) 0(1) 
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Table 5. Bond lengths [Å] and angles [°] for C20H14N2O2. 
 
              
N(1)-N(2) 1.350(2)  C(4)-C(3)-C(18) 130.67(16) 
N(1)-C(9) 1.366(2)  C(5)-C(4)-O(10) 125.83(17) 
N(1)-C(5) 1.393(2)  C(5)-C(4)-C(3) 108.55(16) 
N(2)-C(3) 1.361(2)  O(10)-C(4)-C(3) 125.35(18) 
C(3)-C(4)  1.402(3)  C(4)-C(5)-N(1) 103.71(17) 
C(3)-C(18) 1.460(3)  C(4)-C(5)-C(6) 137.77(17) 
C(4)-C(5)  1.377(3)  N(1)-C(5)-C(6) 118.52(17) 
C(4)-O(10) 1.399(2)  C(7)-C(6)-C(5) 119.41(18) 
C(5)-C(6)  1.406(3)  C(6)-C(7)-C(8) 120.0(2) 
C(6)-C(7)  1.360(3)  C(9)-C(8)-C(7) 120.9(2) 
C(7)-C(8)  1.425(3)  C(8)-C(9)-N(1) 118.93(18) 
C(8)-C(9)  1.347(3)  C(11)-O(10)-C(4) 117.94(15) 
O(10)-C(11) 1.363(2)  O(11)-C(11)-O(10) 123.69(16) 
C(11)-O(11) 1.192(2)  O(11)-C(11)-C(12) 125.57(17) 
C(11)-C(12) 1.487(3)  O(10)-C(11)-C(12) 110.74(16) 
C(12)-C(13) 1.385(3)  C(13)-C(12)-C(17) 120.15(18) 
C(12)-C(17) 1.397(3)  C(13)-C(12)-C(11) 122.43(17) 
C(13)-C(14) 1.390(3)  C(17)-C(12)-C(11) 117.40(18) 
C(14)-C(15) 1.390(3)  C(12)-C(13)-C(14) 120.1(2) 
C(15)-C(16) 1.370(4)  C(13)-C(14)-C(15) 119.3(2) 
C(16)-C(17) 1.383(3)  C(16)-C(15)-C(14) 120.52(19) 
C(18)-C(19) 1.397(3)  C(15)-C(16)-C(17) 120.7(2) 
C(18)-C(23) 1.399(3)  C(16)-C(17)-C(12) 119.2(2) 
C(19)-C(20) 1.372(3)  C(19)-C(18)-C(23) 117.5(2) 
C(20)-C(21) 1.385(3)  C(19)-C(18)-C(3) 119.83(17) 
C(21)-C(22) 1.390(3)  C(23)-C(18)-C(3) 122.61(18) 
C(22)-C(23) 1.375(3)  C(20)-C(19)-C(18) 121.2(2) 
    C(19)-C(20)-C(21) 121.0(2) 
N(2)-N(1)-C(9) 124.48(15) C(20)-C(21)-C(22) 118.5(2) 
N(2)-N(1)-C(5) 113.22(15) C(23)-C(22)-C(21) 120.8(2) 
C(9)-N(1)-C(5) 122.29(18) C(22)-C(23)-C(18) 121.1(2) 
N(1)-N(2)-C(3) 105.18(15)    
N(2)-C(3)-C(4) 109.35(18)    
N(2)-C(3)-C(18) 119.97(17)       
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Table 6. Torsion angles [°] for C20H14N2O2. 
 
        
C(9)-N(1)-N(2)-C(3) -178.44(17) O(11)-C(11)-C(12)-C(13) -175.6(2) 
C(5)-N(1)-N(2)-C(3) 0.1(2) O(10)-C(11)-C(12)-C(13) 3.4(3) 
N(1)-N(2)-C(3)-C(4) -0.1(2) O(11)-C(11)-C(12)-C(17) 2.8(3) 
N(1)-N(2)-C(3)-C(18) 179.00(16) O(10)-C(11)-C(12)-C(17) -178.21(17) 
N(2)-C(3)-C(4)-C(5) 0.0(2) C(17)-C(12)-C(13)-C(14) 0.1(3) 
C(18)-C(3)-C(4)-C(5) -178.89(19) C(11)-C(12)-C(13)-C(14) 178.40(19) 
N(2)-C(3)-C(4)-O(10) 174.35(17) C(12)-C(13)-C(14)-C(15) -0.3(3) 
C(18)-C(3)-C(4)-O(10) -4.6(3) C(13)-C(14)-C(15)-C(16) 0.0(3) 
O(10)-C(4)-C(5)-N(1) -174.27(17) C(14)-C(15)-C(16)-C(17) 0.6(4) 
C(3)-C(4)-C(5)-N(1) 0.0(2) C(15)-C(16)-C(17)-C(12) -0.9(3) 
O(10)-C(4)-C(5)-C(6) 5.4(4) C(13)-C(12)-C(17)-C(16) 0.5(3) 
C(3)-C(4)-C(5)-C(6) 179.7(2) C(11)-C(12)-C(17)-C(16) -177.88(19) 
N(2)-N(1)-C(5)-C(4) 0.0(2) N(2)-C(3)-C(18)-C(19) 1.2(3) 
C(9)-N(1)-C(5)-C(4) 178.50(17) C(4)-C(3)-C(18)-C(19) -180.0(2) 
N(2)-N(1)-C(5)-C(6) -179.78(16) N(2)-C(3)-C(18)-C(23) -177.89(18) 
C(9)-N(1)-C(5)-C(6) -1.2(3) C(4)-C(3)-C(18)-C(23) 1.0(3) 
C(4)-C(5)-C(6)-C(7) -178.9(2) C(23)-C(18)-C(19)-C(20) 0.2(3) 
N(1)-C(5)-C(6)-C(7) 0.7(3) C(3)-C(18)-C(19)-C(20) -178.93(19) 
C(5)-C(6)-C(7)-C(8) 0.1(3) C(18)-C(19)-C(20)-C(21) 0.2(3) 
C(6)-C(7)-C(8)-C(9) -0.4(3) C(19)-C(20)-C(21)-C(22) -0.1(3) 
C(7)-C(8)-C(9)-N(1) -0.1(3) C(20)-C(21)-C(22)-C(23) -0.4(3) 
N(2)-N(1)-C(9)-C(8) 179.33(18) C(21)-C(22)-C(23)-C(18) 0.9(3) 
C(5)-N(1)-C(9)-C(8) 0.9(3) C(19)-C(18)-C(23)-C(22) -0.7(3) 
C(5)-C(4)-O(10)-C(11) -67.5(3) C(3)-C(18)-C(23)-C(22) 178.36(19) 
C(3)-C(4)-O(10)-C(11) 119.2(2)   
C(4)-O(10)-C(11)-O(11) 2.6(3)   
C(4)-O(10)-C(11)-C(12) -176.49(16)     
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ORTEP view of the C20H14N2O2 compound with the numbering scheme adopted. Ellipsoids 
drawn at 30% probability level. Hydrogen atoms are represented by sphere of arbitrary size.  
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